rfhg_132146.1

Basic information about the TSS

---

TSS ID: rfhg_132146.1 TSS ID(Version3): hg_117771.1 hg_117770.1 Species: human Chr: chr11		Start: 504447 End: 504498 Strand: -
Source datasets	FANTOM5|DRA013844|PRJNA4843412
Protocol	CAGE|NETCAGE
TSS cluster detected*	3

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	pELS,CTCF-bound (EH38D2412752,EH38E1513592)
Category:	pELS

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: ENST00000529368.5:-54 GeneID: 6050 HGNC/MGI_ID: HGNC:10074 UniProt_ID: E9PLZ3 Nearer transcript ids and distances:

Gene_name: ribonuclease/angiogenin inhibitor 1 Gene_symbol: RNH1 Gene_synonyms: RAI Gene_source: HGNC:10074

TATA-Box annotation

---

Distance to TSS:	2296
Nearest PromoterID:	NM_002939
Entrez ID:	6050
Nearest Unigene:	Hs.530687
Nearest Refseq:	NM_002939
Nearest Ensembl:	ENSG00000023191
Gene Name:	ribonuclease/angiogenin inhibitor 1
Gene Alias:	RAI|RNH
Gene Type:	protein-coding
CpG%:	0.137255
GC%:	0.788462
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@RNH1 p2@RNH1 p3@RNH1 p4@RNH1 p5@RNH1 p7@RNH1
Sample		p1@RNH1	p2@RNH1	p3@RNH1	p4@RNH1	p5@RNH1	p7@RNH1
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	56.88	54.54	0.00	0.00	0.00	0.00
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	56.45	46.53	0.40	0.00	0.00	0.00
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	64.62	48.80	0.00	0.00	0.00	0.00
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	51.56	45.12	0.21	0.00	0.00	0.00
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	49.49	38.69	0.00	0.00	0.00	0.00
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	47.87	43.80	0.19	0.00	0.00	0.00
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	61.01	92.60	0.22	0.00	0.00	0.00
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	62.98	69.03	0.24	0.00	0.00	0.00
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	66.25	83.78	0.00	0.00	0.00	0.00
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	24.34	97.96	0.00	0.00	0.00	0.00
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	18.59	99.85	0.40	0.00	0.00	0.00
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	17.08	82.53	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	83.18	41.10	75.76	8.38	8.38	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	65.10	31.72	66.15	5.41	6.16	0.45
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	72.67	36.67	70.92	7.25	6.59	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	66.64	32.44	70.92	5.28	5.53	0.75
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	69.02	34.07	69.45	5.46	6.33	1.09
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	57.37	32.90	78.46	6.33	6.75	2.11
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	61.31	36.79	78.37	4.27	7.46	0.53
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	78.83	33.25	62.73	8.12	6.02	0.90
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	75.91	31.14	65.62	8.15	4.41	0.53
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	73.71	29.52	68.70	8.46	5.52	0.69
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	69.67	28.82	58.42	6.98	5.17	1.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	73.29	29.12	65.28	6.55	4.85	0.73
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	76.11	38.70	79.20	6.19	4.39	0.77
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	73.11	38.93	83.24	6.65	3.80	0.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	69.23	32.42	87.36	7.14	6.04	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	86.76	39.84	63.42	9.43	6.84	0.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	76.89	35.70	68.32	7.91	5.01	0.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	84.15	32.94	58.63	8.14	6.15	0.36
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	81.64	32.87	73.69	6.70	5.02	0.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	90.27	33.80	72.88	7.42	5.67	1.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	75.76	32.50	72.59	5.91	4.22	0.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	59.71	32.49	69.60	5.11	4.78	0.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	83.58	39.64	66.57	8.04	6.54	0.93
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	98.30	33.53	59.59	9.96	5.17	1.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	84.20	25.14	65.40	6.54	6.34	1.23
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	78.98	27.00	69.71	5.84	5.24	1.61
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	74.55	35.92	70.50	6.21	5.40	0.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	78.74	27.13	58.82	10.08	6.48	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	84.69	33.64	61.40	9.65	6.12	1.18
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	56.22	26.20	69.10	4.83	5.86	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	90.26	28.26	60.53	6.12	4.01	0.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	88.99	32.17	59.27	7.52	4.20	1.57
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	84.32	27.71	60.23	9.24	5.42	1.61
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	86.31	30.24	56.30	9.07	4.42	0.23
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	94.76	26.39	70.53	8.40	5.28	1.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	82.56	28.31	61.40	6.86	4.47	0.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	89.29	29.68	70.14	6.46	5.27	0.96
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	80.27	27.09	58.03	7.89	5.66	1.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	81.98	31.36	58.41	5.12	4.10	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	107.41	38.92	64.71	6.89	5.34	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	13.99	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	107.52	31.23	68.84	7.10	3.55	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	109.69	30.49	54.02	10.60	3.98	0.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	13.42	7.55	18.46	0.84	0.84	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	51.44	22.96	35.36	2.30	3.21	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	123.49	25.28	50.56	5.51	5.51	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	127.83	28.91	50.74	8.35	4.18	0.96
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	52.18	21.37	37.09	4.40	3.14	0.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	140.31	14.81	45.12	5.64	3.53	1.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	121.69	30.28	43.18	8.97	3.93	0.56
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	19.11	9.55	14.33	2.39	1.59	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	71.69	16.31	30.58	4.42	3.40	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	133.87	23.72	52.31	6.82	5.85	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	151.93	28.75	69.22	9.23	5.68	1.06
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	16.16	16.16	48.49	0.00	16.16	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	7.90	15.79	15.79	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	142.35	23.40	85.80	13.65	5.85	2.93
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	133.39	23.80	90.25	10.91	5.95	0.50
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	132.29	21.11	70.37	5.63	7.97	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	93.73	32.13	67.89	7.29	7.95	0.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	140.13	25.98	66.82	8.04	7.11	0.93
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	148.90	24.15	67.26	8.26	5.50	0.61
Adipocyte - breast, donor1	11376-118A8	99.62	35.16	80.14	6.02	2.85	0.95
Adipocyte - breast, donor2	11327-117E4	70.91	24.87	42.51	4.49	1.60	0.16
Adipocyte - omental, donor1	11473-119C6	69.72	26.85	31.17	3.05	1.53	0.51
Adipocyte - omental, donor2	11474-119C7	112.87	24.67	33.64	5.98	0.00	1.49
Adipocyte - omental, donor3	11475-119C8	83.73	23.11	17.75	5.02	0.33	0.67
Adipocyte - perirenal, donor1	11476-119C9	105.91	30.62	21.69	5.74	3.19	0.64
Adipocyte - subcutaneous, donor1	11259-116F8	56.07	19.79	12.09	3.30	0.00	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	67.29	25.74	41.55	8.58	0.45	0.90
Adipocyte - subcutaneous, donor3	11408-118E4	52.31	54.57	9.04	2.95	0.52	0.52
Adipocyte differentiation, day04, donor1	13019-139D4	51.24	17.60	23.27	5.28	1.37	0.98
Adipocyte differentiation, day04, donor2	13022-139D7	37.32	10.04	3.35	2.32	0.00	0.26
Adipocyte differentiation, day04, donor3	13025-139E1	69.97	22.30	33.45	9.20	2.79	0.84
Adipocyte differentiation, day04, donor4	13028-139E4	54.08	21.75	22.34	4.70	0.59	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	43.76	14.72	8.61	2.65	0.97	0.24
Adipocyte differentiation, day08, donor2	13023-139D8	47.44	16.14	18.40	3.87	0.97	0.65
Adipocyte differentiation, day08, donor3	13026-139E2	51.19	11.20	23.99	7.46	2.13	0.00
Adipocyte differentiation, day08, donor4	13029-139E5	45.63	17.81	15.58	2.23	2.78	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	68.21	19.96	16.22	4.16	0.00	0.00
Adipocyte differentiation, day12, donor2	13024-139D9	35.67	12.31	17.58	3.01	2.01	0.50
Adipocyte differentiation, day12, donor3	13027-139E3	45.81	16.04	29.78	1.64	1.96	0.98
Adipocyte differentiation, day12, donor4	13030-139E6	40.19	13.40	13.09	1.83	1.22	0.30
Alveolar Epithelial Cells, donor1	11510-119G7	83.76	26.74	8.18	0.66	0.22	0.44
Alveolar Epithelial Cells, donor2	11590-120G6	178.93	30.84	11.47	2.51	0.36	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	57.50	23.96	8.39	2.40	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	79.70	15.65	2.52	0.18	0.36	0.00
Amniotic Epithelial Cells, donor2	11613-122A2	115.47	20.08	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	103.96	17.26	4.31	0.21	0.82	0.00
Anulus Pulposus Cell, donor1	11248-116E6	63.62	41.31	15.68	5.03	2.06	0.69
Anulus Pulposus Cell, donor2	11463-119B5	70.29	37.23	10.29	5.14	1.71	0.98
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	67.84	22.02	7.19	0.45	0.45	0.45
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	66.42	28.65	6.51	1.30	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	62.07	36.38	2.14	0.00	0.00	2.14
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	70.25	23.02	8.07	0.90	0.60	0.30
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	67.03	21.50	5.06	1.26	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	65.35	21.12	2.64	0.66	0.66	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	58.80	20.14	4.22	1.95	0.32	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	61.65	29.13	5.34	0.97	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	63.55	29.10	5.34	0.59	0.00	0.59
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	74.57	20.72	7.16	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	74.74	23.22	5.81	1.45	1.45	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	60.18	37.61	8.78	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	62.60	27.35	4.12	1.15	0.16	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	80.52	23.20	5.46	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	69.36	26.69	4.22	1.36	0.30	0.15
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	75.01	27.33	9.11	0.54	0.00	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	67.26	19.65	2.65	1.89	0.38	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	63.08	25.66	4.54	1.07	0.53	0.27
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	96.57	21.46	5.85	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	67.50	23.05	2.82	1.49	0.33	0.33
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	74.44	33.62	8.41	4.80	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	74.34	17.70	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	63.98	20.24	2.74	0.34	0.69	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	83.90	25.17	12.58	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	65.53	23.79	2.43	0.49	0.49	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	69.82	25.04	3.42	1.14	1.52	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	76.32	27.86	2.42	1.21	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	101.47	28.50	3.42	3.42	1.71	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	63.49	22.87	3.63	0.43	0.21	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	70.20	30.20	4.39	1.55	0.52	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	69.91	30.50	3.75	0.94	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	61.42	26.05	2.57	0.64	0.00	0.32
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	84.19	25.68	2.14	0.71	0.71	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	64.93	28.66	2.34	0.00	1.17	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	75.87	24.09	0.90	2.11	0.30	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	91.48	35.64	3.56	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	76.28	26.45	4.07	0.51	0.00	0.51
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	68.77	23.69	3.82	1.53	0.25	0.51
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	69.26	27.96	3.18	0.00	1.27	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	69.48	19.85	3.88	0.43	0.00	0.43
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	65.41	21.38	3.18	1.06	0.85	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	69.02	25.23	6.38	1.16	0.58	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	60.46	22.67	2.83	1.89	1.89	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	63.57	24.92	3.56	1.19	0.34	0.51
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	92.65	30.11	4.63	0.00	2.32	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	88.73	27.46	4.23	2.11	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	66.47	23.16	4.72	1.07	0.21	0.64
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	57.16	34.29	3.61	1.80	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	73.63	25.51	5.83	1.46	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	70.57	24.60	3.91	1.61	0.46	0.69
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	91.81	30.60	2.55	2.55	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	69.15	35.08	5.85	1.27	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	68.74	28.08	2.68	1.45	0.41	0.41
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	65.48	33.35	4.59	0.61	0.61	0.31
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	62.62	20.55	2.87	0.96	0.96	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	64.30	25.28	3.33	0.22	0.44	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	74.76	32.04	6.10	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	66.47	29.91	3.88	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	65.14	20.92	3.44	0.79	0.00	0.26
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	51.25	35.25	3.27	2.54	0.00	0.36
Astrocyte - cerebellum, donor1	11500-119F6	89.90	40.90	1.35	0.98	0.61	0.00
Astrocyte - cerebellum, donor2	11580-120F5	114.33	47.24	0.86	1.20	0.51	0.17
Astrocyte - cerebellum, donor3	11661-122F5	82.43	39.85	5.87	2.31	0.84	0.63
Astrocyte - cerebral cortex, donor1	11235-116D2	53.68	10.81	1.74	1.39	0.35	0.00
Astrocyte - cerebral cortex, donor2	11316-117D2	74.09	12.62	1.62	0.65	0.32	0.00
Astrocyte - cerebral cortex, donor3	11392-118C6	76.67	19.54	2.24	1.64	0.60	0.15
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	41.63	41.97	0.00	2.06	0.00	0.34
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	38.84	41.72	0.13	2.00	0.00	0.25
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	35.85	37.67	0.00	1.48	0.00	0.11
Basophils, donor1	12241-129G9	71.14	15.43	30.60	4.97	1.31	0.52
Basophils, donor2	12242-129H1	51.95	12.63	14.07	1.80	0.72	0.00
Basophils, donor3	12243-129H2	81.44	9.55	33.22	7.06	0.88	0.29
Bronchial Epithelial Cell, donor1	11511-119G8	79.13	24.36	47.43	1.08	0.43	0.00
Bronchial Epithelial Cell, donor2	11591-120G7	223.56	38.40	27.43	2.29	3.20	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	157.82	28.69	14.35	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	141.85	24.48	16.32	0.63	1.88	0.63
Bronchial Epithelial Cell, donor5	11457-119A8	166.98	25.37	23.50	2.29	0.21	0.21
Bronchial Epithelial Cell, donor6	11461-119B3	113.07	26.02	20.50	0.46	1.38	0.23
Bronchial Epithelial Cell, donor7	11769-123I5	94.83	25.73	14.76	0.36	0.36	0.00
Burkitt's lymphoma cell line:DAUDI	10422-106C8	17.73	48.95	0.00	0.00	0.00	0.00
Burkitt's lymphoma cell line:RAJI	10476-106I8	28.41	51.94	0.00	0.00	0.00	0.00
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	40.29	33.90	7.35	3.20	0.64	0.00
CD133+ stem cells - cord blood derived, pool1	12223-129E9	20.68	10.34	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	72.14	20.29	33.81	5.64	1.13	0.00
CD14+ Monocytes, donor2	11305-117B9	65.52	9.47	26.36	5.20	0.56	0.19
CD14+ Monocytes, donor3	11381-118B4	70.25	11.85	20.64	4.83	1.54	0.00
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	97.65	47.55	103.31	29.72	9.06	1.98
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	78.47	45.11	98.56	10.24	8.72	2.27
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	73.64	39.45	70.35	16.77	9.20	1.64
CD14+ monocytes - mock treated, donor1	11863-125A9	65.19	8.09	53.92	11.42	2.89	0.58
CD14+ monocytes - mock treated, donor2	11873-125C1	51.30	8.15	54.01	4.83	1.51	0.30
CD14+ monocytes - mock treated, donor3	11883-125D2	58.99	8.29	49.04	5.92	2.37	0.00
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	48.55	5.69	30.97	8.70	1.51	0.50
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	40.57	7.73	37.54	5.52	2.48	0.55
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	60.99	8.18	31.24	6.20	0.25	0.50
CD14+ monocytes - treated with BCG, donor1	11860-125A6	57.96	6.07	25.85	11.55	1.57	0.39
CD14+ monocytes - treated with BCG, donor2	11870-125B7	56.80	6.59	35.43	3.03	0.71	0.00
CD14+ monocytes - treated with BCG, donor3	11880-125C8	82.26	11.10	38.96	6.09	2.18	0.00
CD14+ monocytes - treated with Candida, donor1	11868-125B5	49.17	4.68	27.63	5.85	0.47	0.70
CD14+ monocytes - treated with Candida, donor2	11878-125C6	41.19	6.86	24.82	4.22	0.53	0.53
CD14+ monocytes - treated with Candida, donor3	11888-125D7	67.67	5.55	34.39	7.77	1.11	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	48.05	6.54	40.46	9.97	1.04	1.34
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	43.30	9.98	38.31	4.19	1.20	0.60
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	63.29	10.41	49.97	6.25	1.87	0.21
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	59.94	6.18	42.10	9.84	1.60	0.46
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	47.28	9.05	35.29	4.07	1.81	0.00
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	55.43	6.11	37.97	4.36	1.31	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	62.94	6.72	27.71	7.80	2.15	0.81
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	61.76	7.15	41.70	5.76	1.74	0.17
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	64.39	7.15	34.09	2.95	1.68	0.84
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	52.91	4.23	25.17	9.19	0.55	0.55
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	36.64	7.05	25.36	2.47	0.70	0.00
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	48.70	3.95	19.74	3.07	0.44	0.44
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	60.16	4.18	28.42	10.64	2.09	0.70
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	47.20	11.15	31.22	6.69	1.12	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	70.27	11.86	35.35	6.04	1.29	0.22
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	47.09	4.50	20.47	6.96	1.23	0.82
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	36.39	7.65	25.03	3.94	1.85	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	52.89	7.19	28.77	3.02	1.39	0.00
CD14+CD16+ Monocytes, donor1	11789-124B7	109.85	28.12	121.84	13.08	5.45	1.53
CD14+CD16+ Monocytes, donor2	11801-124D1	144.37	35.57	150.84	16.40	6.47	0.46
CD14+CD16+ Monocytes, donor3	11912-125G4	113.29	31.41	80.36	14.08	6.07	0.43
CD14+CD16- Monocytes, donor1	11788-124B6	105.27	36.13	118.04	21.33	6.07	0.47
CD14+CD16- Monocytes, donor2	11799-124C8	99.02	30.56	81.91	17.12	4.54	0.52
CD14+CD16- Monocytes, donor3	11910-125G2	55.30	20.51	31.22	8.92	2.68	0.45
CD14-CD16+ Monocytes, donor1	11790-124B8	168.42	28.07	130.39	15.57	5.87	1.28
CD14-CD16+ Monocytes, donor2	11800-124C9	152.82	39.08	134.81	10.76	5.71	0.88
CD14-CD16+ Monocytes, donor3	11911-125G3	146.12	28.42	94.11	14.74	4.42	0.42
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	52.84	22.36	2.03	2.03	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	60.34	20.34	6.10	5.42	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	59.03	43.50	3.11	2.07	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	64.50	29.32	11.19	3.20	1.60	0.00
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	57.90	39.13	1.61	2.68	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	55.45	24.57	7.02	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	55.69	36.08	7.06	5.49	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	54.05	25.05	6.59	1.32	0.00	0.00
CD19+ B Cells, donor1	11544-120B5	64.93	24.66	1.64	0.82	0.00	0.00
CD19+ B Cells, donor2	11624-122B4	66.01	15.23	4.35	2.18	0.00	0.00
CD19+ B Cells, donor3	11705-123B4	65.63	10.60	2.02	1.01	0.00	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	42.43	21.42	18.18	1.62	0.81	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	57.53	25.97	17.58	0.80	0.40	0.00
CD34+ Progenitors, donor1	11545-120B6	20.08	6.02	0.00	0.00	0.00	0.00
CD34+ Progenitors, donor2	11625-122B5	37.08	7.87	2.81	0.56	0.00	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	54.48	23.30	21.79	6.39	1.88	0.38
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	50.73	37.43	25.25	3.16	1.13	0.45
CD4+ T Cells, donor1	11225-116C1	61.41	12.50	0.71	0.00	0.00	0.00
CD4+ T Cells, donor2	11306-117C1	78.38	12.25	0.61	0.61	0.00	0.00
CD4+ T Cells, donor3	11382-118B5	89.36	19.21	0.61	0.30	0.00	0.30
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	46.71	31.14	0.00	0.26	0.00	0.26
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	48.74	34.14	0.00	0.22	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	40.53	39.09	0.29	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	94.82	36.98	0.95	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	93.41	47.76	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	62.63	52.74	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	37.57	25.29	0.43	0.87	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	62.19	26.10	0.68	2.54	0.00	0.17
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	51.75	22.57	1.13	1.29	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	69.49	22.86	0.45	0.45	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	90.14	29.70	0.00	1.05	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	57.20	27.72	0.44	1.76	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	48.91	35.00	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	50.90	27.43	0.00	0.00	0.21	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	55.80	27.06	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	82.94	53.03	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	77.18	51.99	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	73.52	37.66	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	50.62	34.49	0.19	0.56	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	59.14	30.33	0.43	0.43	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	48.12	23.54	0.00	0.42	0.21	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	84.94	28.82	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	81.88	34.23	0.00	0.43	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	50.12	24.41	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	67.80	47.51	1.48	2.97	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	63.70	37.85	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	54.44	29.31	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	72.00	49.57	6.65	1.11	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	64.54	43.68	3.19	0.98	0.25	0.00
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	60.06	41.58	3.08	3.08	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	62.67	46.20	6.80	2.51	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	78.94	38.78	0.00	0.00	0.00	0.00
CD8+ T Cells, donor1	11226-116C2	83.16	22.92	0.00	0.00	0.00	0.00
CD8+ T Cells, donor2	11307-117C2	60.44	12.01	0.00	0.00	0.00	0.00
CD8+ T Cells, donor3	11383-118B6	81.30	17.93	0.00	0.00	0.00	0.00
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	66.98	23.86	0.00	0.00	0.00	0.00
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	66.86	28.28	0.00	0.00	0.00	0.00
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	55.81	32.01	0.00	0.00	0.00	0.00
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	63.94	25.22	0.00	0.00	0.00	0.00
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	63.84	26.16	0.00	0.00	0.00	0.00
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	63.90	25.69	0.00	0.00	0.00	0.00
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	76.48	28.25	0.00	0.00	0.00	0.00
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	76.59	32.64	0.00	0.00	0.00	0.00
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	69.42	31.19	0.00	0.00	0.00	0.00
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	60.07	41.96	0.00	0.00	0.00	0.00
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	64.49	36.31	0.00	0.00	0.00	0.00
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	62.61	34.37	0.00	0.00	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	43.78	29.33	0.00	0.00	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	46.00	24.14	0.46	0.00	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	41.77	14.17	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	75.27	24.13	0.36	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	70.78	23.02	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	56.80	24.51	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	71.94	27.57	0.32	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	72.28	26.76	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	66.36	25.65	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	57.75	34.04	0.00	0.00	0.38	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	50.45	29.56	0.39	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	43.87	30.26	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	29.71	43.36	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	36.37	46.86	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	27.05	41.07	0.00	0.00	0.00	0.00
Cardiac Myocyte, donor1	11525-119I4	82.25	47.52	21.93	7.31	5.48	0.00
Cardiac Myocyte, donor2	11605-120I3	67.69	19.76	7.91	3.95	0.49	0.49
Cardiac Myocyte, donor3	11686-122I3	83.98	21.26	43.04	11.15	2.74	1.05
Chondrocyte - de diff, donor1	11261-116G1	98.11	48.19	110.59	6.59	3.81	0.69
Chondrocyte - de diff, donor2	11338-117F6	85.29	33.05	48.33	6.75	3.91	0.36
Chondrocyte - de diff, donor3	11410-118E6	80.67	36.64	74.41	4.66	3.98	0.80
Chondrocyte - re diff, donor2	11339-117F7	50.13	18.80	24.17	2.69	2.69	0.00
Chondrocyte - re diff, donor3	11411-118E7	82.50	33.16	28.31	4.85	1.62	0.81
Ciliary Epithelial Cells, donor1	11242-116D9	55.77	19.85	0.46	1.38	0.00	0.11
Ciliary Epithelial Cells, donor2	11323-117D9	63.92	23.09	0.86	0.86	0.00	0.00
Ciliary Epithelial Cells, donor3	11399-118D4	60.27	19.74	1.24	1.24	0.00	0.00
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	86.84	39.98	10.91	1.93	0.92	0.28
Corneal Epithelial Cells, donor1	11526-119I5	90.02	32.94	15.37	1.32	0.44	0.00
Corneal Epithelial Cells, donor2	11606-120I4	102.38	19.34	32.99	1.14	1.14	1.14
Corneal Epithelial Cells, donor3	11687-122I4	102.25	22.50	31.70	1.79	1.28	0.00
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	111.44	26.58	149.58	14.20	8.58	2.81
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	123.01	19.56	161.81	17.66	5.68	2.21
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	127.68	31.06	165.63	17.25	10.35	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	106.48	15.23	128.29	20.52	11.01	2.05
Dendritic Cells - plasmacytoid, donor1	11228-116C4	74.48	16.06	11.27	2.39	0.34	0.00
Dendritic Cells - plasmacytoid, donor2	11309-117C4	82.91	13.06	9.79	1.96	0.65	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	68.72	13.55	5.81	0.00	0.97	0.00
Endothelial Cells - Aortic, donor0	11207-116A1	67.04	18.18	6.84	10.34	0.67	1.00
Endothelial Cells - Aortic, donor1	11263-116G3	73.93	21.71	15.84	8.21	1.76	0.59
Endothelial Cells - Aortic, donor2	11340-117F8	77.20	13.86	6.79	11.03	1.70	0.00
Endothelial Cells - Aortic, donor3	11412-118E8	83.75	10.62	6.68	9.83	1.57	1.57
Endothelial Cells - Artery, donor1	11264-116G4	77.37	18.03	7.27	8.14	0.58	0.87
Endothelial Cells - Artery, donor2	11341-117F9	98.11	25.65	4.00	9.41	0.24	0.47
Endothelial Cells - Artery, donor3	11413-118E9	78.89	11.75	8.06	7.71	1.23	0.53
Endothelial Cells - Lymphatic, donor1	11236-116D3	61.84	15.29	3.99	6.21	0.66	0.22
Endothelial Cells - Lymphatic, donor2	11317-117D3	47.77	15.52	5.17	3.65	1.22	0.00
Endothelial Cells - Lymphatic, donor3	11393-118C7	36.93	9.58	2.26	3.95	0.00	0.00
Endothelial Cells - Microvascular, donor1	11265-116G5	94.79	14.56	9.21	12.18	1.49	1.49
Endothelial Cells - Microvascular, donor2	11342-117G1	47.38	12.50	7.81	15.10	1.04	0.52
Endothelial Cells - Microvascular, donor3	11414-118F1	75.86	8.93	7.80	10.49	1.42	1.28
Endothelial Cells - Thoracic, donor1	11266-116G6	77.62	17.61	3.60	4.00	1.20	0.00
Endothelial Cells - Thoracic, donor2	11343-117G2	84.38	15.20	3.14	6.81	0.00	0.00
Endothelial Cells - Umbilical vein, donor1	11243-116E1	50.07	13.54	4.10	3.85	0.62	0.00
Endothelial Cells - Umbilical vein, donor2	11324-117E1	44.32	6.08	2.61	4.56	0.22	0.22
Endothelial Cells - Umbilical vein, donor3	11400-118D5	48.48	7.82	2.44	3.54	0.49	0.61
Endothelial Cells - Vein, donor1	11267-116G7	86.45	18.20	2.28	5.69	0.00	0.00
Endothelial Cells - Vein, donor2	11344-117G3	71.95	14.67	2.79	5.59	0.00	0.00
Endothelial Cells - Vein, donor3	11416-118F3	86.35	16.01	4.71	9.11	0.47	0.31
Eosinophils, donor1	12244-129H3	30.49	15.25	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	42.91	3.30	0.00	0.00	0.00	0.00
Eosinophils, donor3	12246-129H5	28.53	0.00	0.00	0.00	3.57	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	73.54	15.64	27.36	1.47	1.22	0.00
Esophageal Epithelial Cells, donor2	11587-120G3	93.61	39.52	45.76	0.00	2.08	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	65.08	48.81	48.81	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	90.31	19.70	22.58	1.23	2.05	0.82
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	57.37	31.09	67.44	6.79	3.94	0.99
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	93.06	38.57	146.36	13.65	3.68	1.63
Fibroblast - Aortic Adventitial, donor1	11245-116E3	69.86	23.16	51.30	6.31	4.00	0.61
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	86.80	35.48	139.20	10.78	5.32	1.23
Fibroblast - Aortic Adventitial, donor2	11326-117E3	62.12	27.11	73.62	8.65	2.95	1.79
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	74.57	20.82	171.27	7.38	3.95	0.00
Fibroblast - Aortic Adventitial, donor3	11401-118D6	74.41	18.94	57.14	13.62	3.99	1.99
Fibroblast - Cardiac, donor1	11268-116G8	119.30	32.66	45.36	8.17	1.81	0.45
Fibroblast - Cardiac, donor2	11345-117G4	104.60	29.56	18.95	3.79	2.27	0.76
Fibroblast - Cardiac, donor3	11417-118F4	103.30	26.65	10.72	1.58	1.10	0.16
Fibroblast - Cardiac, donor4	11452-119A3	37.89	22.13	11.21	4.85	1.52	0.61
Fibroblast - Cardiac, donor5	11456-119A7	78.68	15.86	20.18	8.50	1.27	1.02
Fibroblast - Cardiac, donor6	11460-119B2	80.19	15.61	7.73	3.49	0.61	0.45
Fibroblast - Choroid Plexus, donor1	11492-119E7	58.96	29.61	2.81	1.61	0.00	0.27
Fibroblast - Choroid Plexus, donor2	11572-120E6	72.05	28.47	6.90	1.73	0.00	0.00
Fibroblast - Choroid Plexus, donor3	11653-122E6	90.82	38.08	2.93	0.00	0.00	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	68.73	55.58	28.37	5.54	1.85	0.00
Fibroblast - Conjunctival, donor3	11692-122I9	56.82	33.24	35.62	8.14	2.54	0.17
Fibroblast - Dermal, donor1	11269-116G9	78.18	22.54	44.61	11.74	2.35	0.70
Fibroblast - Dermal, donor2	11346-117G5	90.09	29.24	41.98	12.74	5.66	1.89
Fibroblast - Dermal, donor3	11418-118F5	84.14	23.09	53.31	15.59	3.63	1.57
Fibroblast - Dermal, donor4	11450-119A1	45.22	13.34	2.94	1.47	0.23	0.00
Fibroblast - Dermal, donor5	11454-119A5	81.82	23.38	7.85	3.84	0.35	0.35
Fibroblast - Dermal, donor6	11458-119A9	88.03	24.53	6.50	2.76	0.16	0.16
Fibroblast - Gingival, donor1	11237-116D4	46.85	23.95	42.06	7.29	3.54	0.62
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	97.73	33.80	75.72	10.48	3.14	0.79
Fibroblast - Gingival, donor2	11318-117D4	85.66	32.29	9.49	3.56	0.66	0.13
Fibroblast - Gingival, donor3	11394-118C8	66.13	26.30	72.23	9.77	5.03	1.26
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	73.76	35.32	35.32	12.47	1.04	2.08
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	82.82	32.60	49.69	7.22	3.35	1.06
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	96.66	25.10	34.30	8.57	1.56	1.09
Fibroblast - Gingival, donor6 (control)	11922-125H5	86.82	25.56	43.41	6.49	3.38	0.68
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	73.40	29.99	10.59	3.18	0.71	0.00
Fibroblast - Gingival, donor7 (control)	11924-125H7	90.09	37.00	36.12	7.02	2.49	0.73
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	93.81	30.82	71.04	5.45	2.73	0.95
Fibroblast - Gingival, donor8 (control)	11926-125H9	86.44	31.15	26.33	3.29	1.21	0.33
Fibroblast - Gingival, donor9 (control)	11927-125I1	74.84	34.04	67.50	7.78	5.58	1.17
Fibroblast - Lung, donor1	11270-116H1	110.11	28.55	4.08	4.08	1.36	1.36
Fibroblast - Lung, donor2	11347-117G6	55.21	26.86	2.98	1.49	1.49	0.00
Fibroblast - Lung, donor3	11419-118F6	126.62	36.72	11.61	4.01	1.69	0.21
Fibroblast - Lymphatic, donor1	11506-119G3	119.12	40.82	40.82	14.16	2.50	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	72.73	22.38	29.37	11.19	1.40	1.40
Fibroblast - Lymphatic, donor3	11667-122G2	92.08	33.59	45.90	14.55	3.36	1.68
Fibroblast - Mammary, donor1	11540-120B1	72.26	28.42	19.08	5.28	1.22	1.22
Fibroblast - Mammary, donor2	11620-122A9	103.85	7.99	51.92	7.99	3.99	0.00
Fibroblast - Mammary, donor3	11701-123A9	53.61	41.69	35.74	11.91	5.96	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	67.50	15.91	10.28	1.94	0.97	0.39
Fibroblast - Periodontal Ligament, donor2	11319-117D5	65.07	21.99	6.83	1.52	0.61	0.15
Fibroblast - Periodontal Ligament, donor3	11395-118C9	55.08	18.36	30.29	5.81	2.75	0.31
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	80.90	30.53	27.48	6.87	2.29	0.00
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	124.20	38.88	62.37	13.50	5.94	0.81
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	89.18	31.66	37.00	8.00	3.13	1.74
Fibroblast - Pulmonary Artery, donor1	11250-116E8	96.38	24.65	23.99	7.96	2.87	0.55
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	80.26	13.41	14.22	4.67	0.81	0.41
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	74.17	43.43	8.69	3.34	0.67	0.67
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	86.58	43.49	14.23	3.95	1.98	0.40
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	128.59	21.04	29.97	3.37	1.39	0.00
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	64.48	28.06	16.16	3.91	1.07	0.00
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	77.45	28.77	53.61	3.94	2.96	0.99
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	151.93	37.01	118.54	9.33	3.31	0.90
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	80.96	26.45	47.82	10.04	3.02	0.76
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	197.90	54.16	146.02	7.34	4.05	0.25
Fibroblast - skin normal, donor1	11553-120C5	112.07	40.86	54.97	6.07	2.13	0.33
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	103.86	27.27	105.47	8.62	5.21	0.40
Fibroblast - skin normal, donor2	11561-120D4	96.44	21.20	50.33	8.04	2.01	0.90
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	180.13	32.94	134.19	10.28	3.32	0.30
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	72.57	27.34	47.39	7.95	2.57	0.66
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	65.82	33.51	34.70	4.62	2.56	0.17
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	113.97	30.87	45.00	3.61	2.30	0.33
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	95.76	30.25	21.41	3.73	1.07	0.64
Fibroblast - skin walker warburg, donor1	11554-120C6	95.14	30.03	13.66	2.19	1.18	0.17
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	59.43	26.66	40.30	3.14	1.88	0.00
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	0.00	0.00	22.16	0.00	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	77.57	34.86	57.52	0.00	0.87	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	92.75	12.48	21.50	0.35	0.69	0.69
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	71.57	14.83	10.67	0.52	0.26	0.00
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	62.86	14.31	17.89	1.02	2.56	0.26
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	28.33	10.72	0.00	0.77	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	27.44	16.59	0.64	0.64	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	21.97	29.38	0.00	0.00	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	44.40	17.37	0.28	0.00	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	41.10	15.53	0.00	0.00	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	26.55	25.16	0.40	0.00	0.20	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	44.67	20.09	0.26	0.00	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	55.12	15.33	0.65	0.33	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	22.55	30.96	0.00	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	25.58	16.11	0.71	0.14	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	25.00	16.87	0.49	0.12	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	22.03	14.51	0.27	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	30.35	15.12	1.49	0.12	0.25	0.00
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	23.26	14.26	0.55	0.14	0.00	0.14
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	16.67	12.60	1.02	0.41	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	38.56	19.17	1.14	0.23	0.23	0.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	26.91	15.45	1.49	0.25	0.50	0.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	17.05	12.90	1.09	0.66	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	53.48	22.75	0.30	0.30	0.30	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	36.72	15.26	0.79	0.16	0.48	0.16
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	30.39	14.30	0.89	0.00	0.22	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	53.43	17.54	0.81	0.81	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	44.96	17.47	0.17	0.00	0.34	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	32.37	18.71	0.71	0.27	0.09	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	41.73	28.41	1.25	0.42	0.10	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	49.70	27.32	0.85	0.51	0.34	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	42.60	17.37	0.44	0.33	0.33	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	36.36	18.64	0.83	0.25	0.17	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	44.92	21.64	1.23	0.00	0.20	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	51.99	24.76	0.83	0.41	0.41	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	40.35	19.14	0.69	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	49.20	22.51	0.83	0.00	0.33	0.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	53.12	25.79	1.32	0.22	0.44	0.22
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	53.75	31.24	1.35	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	40.20	21.88	0.32	0.16	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	54.20	32.71	0.96	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	56.76	21.41	0.76	0.19	0.09	0.00
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	53.15	29.90	0.32	0.47	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	47.74	29.80	0.91	0.91	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	52.58	22.48	0.94	0.42	0.00	0.10
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	46.77	37.32	0.66	0.66	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	53.30	30.58	0.28	0.28	0.28	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	56.02	19.54	0.56	0.37	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	61.50	33.43	1.07	0.00	0.27	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	62.43	28.76	0.31	0.77	0.00	0.15
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	57.38	28.37	0.91	0.52	0.13	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	49.34	29.55	0.54	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	67.10	28.39	1.11	0.00	0.18	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	62.72	21.27	0.00	0.00	0.22	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	26.78	27.77	0.00	0.99	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	62.66	25.46	1.19	0.13	0.26	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	66.58	25.02	0.61	0.20	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	21.86	24.40	0.00	0.00	0.00	0.00
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	17.32	13.34	0.20	0.20	0.00	0.00
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	23.11	15.10	0.15	0.00	0.00	0.00
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	32.53	14.93	0.41	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	39.74	22.53	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	33.62	29.95	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	22.60	19.37	0.46	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	19.80	42.07	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	37.91	21.66	0.00	0.00	0.39	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	30.48	27.28	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	22.60	27.82	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	31.25	19.53	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	28.83	17.71	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	46.65	16.66	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	29.64	14.26	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	24.84	18.96	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	26.00	15.10	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	38.49	20.36	0.32	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	31.25	16.98	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	39.67	18.79	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	36.08	28.06	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	28.41	16.87	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	40.66	20.33	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	42.25	16.98	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	37.28	17.26	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	52.68	21.07	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	35.75	13.07	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	39.44	15.32	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	42.81	19.40	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	29.67	21.58	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	43.48	22.25	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	27.33	29.82	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	37.28	18.87	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	38.62	19.31	0.00	0.00	0.60	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	49.34	24.42	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	30.71	26.32	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	44.40	23.19	0.49	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	48.40	28.33	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	49.59	21.59	0.58	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	41.69	28.53	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	35.60	23.74	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	56.71	17.91	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	55.32	21.35	0.00	0.00	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	123.26	41.09	7.99	2.28	1.14	2.28
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	122.25	43.24	15.80	1.66	2.08	0.00
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	129.31	29.24	20.24	7.87	0.00	2.25
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	62.80	32.98	37.74	9.20	0.95	0.63
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	61.83	37.60	73.10	6.68	2.92	0.42
Hep-2 cells mock treated, biol_rep1	11898-125E8	100.49	65.80	0.12	0.00	0.00	0.00
Hep-2 cells mock treated, biol_rep2	11899-125E9	100.61	75.29	0.17	0.00	0.00	0.00
Hep-2 cells mock treated, biol_rep3	11900-125F1	92.59	65.29	0.00	0.00	0.00	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	110.07	73.24	0.22	0.00	0.00	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	100.79	74.79	0.00	0.00	0.00	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	90.85	59.42	0.00	0.00	0.00	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	108.72	72.11	0.37	0.00	0.00	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	91.95	74.97	0.00	0.00	0.00	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	96.75	57.67	0.32	0.00	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	83.94	7.28	2.24	1.12	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	89.16	23.37	4.76	2.60	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	84.60	34.37	13.22	5.29	2.64	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	94.18	31.04	38.80	16.58	2.12	1.41
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	111.16	39.23	46.50	16.71	2.91	2.91
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	102.81	21.85	29.37	7.87	1.22	1.05
Hepatocyte, donor1	11523-119I2	77.48	43.58	0.00	0.00	0.00	0.00
Hepatocyte, donor2	11603-120I1	94.81	22.62	1.08	1.08	0.00	0.00
Hepatocyte, donor3	11684-122I1	60.74	44.79	4.91	1.23	1.23	0.00
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	33.29	39.81	0.00	0.00	0.00	0.00
Intestinal epithelial cells (polarized), donor1	11246-116E4	38.98	33.56	0.00	0.00	0.00	0.00
Iris Pigment Epithelial Cells, donor1	11530-119I9	50.63	22.78	2.33	2.06	0.69	0.14
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	114.62	54.13	9.55	3.18	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	93.45	46.73	6.68	6.68	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	135.42	108.33	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	78.91	42.92	2.77	2.77	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	70.07	57.56	0.00	5.01	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	166.16	47.47	23.74	0.00	0.00	11.87
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	84.58	53.82	2.56	2.56	2.56	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	105.13	68.56	4.57	4.57	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	99.08	35.74	9.75	3.25	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	96.70	53.35	5.00	3.33	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	65.35	43.57	3.63	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	121.76	75.44	10.59	2.65	1.32	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	75.39	55.43	8.87	3.33	0.00	1.11
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	104.77	47.14	5.24	5.24	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	78.10	60.47	9.45	3.15	0.00	0.63
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	102.08	29.39	9.28	1.55	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	58.54	29.27	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	87.86	51.68	7.11	3.23	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	125.57	35.42	3.22	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	95.59	71.69	0.00	11.95	0.00	11.95
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	80.67	57.04	8.96	3.26	0.81	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	84.80	56.25	7.14	4.20	0.84	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	158.10	57.49	0.00	14.37	0.00	14.37
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	94.03	39.38	7.23	3.21	1.61	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	90.48	31.39	3.69	0.92	0.92	0.92
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	60.32	30.16	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	73.17	45.32	1.89	1.89	0.47	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	79.81	34.47	2.72	2.72	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	73.71	14.74	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	102.23	38.74	9.69	3.23	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	91.47	44.47	15.25	5.08	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	49.29	115.01	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	83.54	46.55	4.46	1.91	1.28	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	100.25	47.39	1.82	1.82	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	79.02	0.00	15.80	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	95.68	54.98	8.57	0.71	0.71	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	122.78	39.82	6.64	3.32	3.32	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	187.64	20.85	20.85	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	67.91	29.32	6.79	2.78	0.62	0.31
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	114.14	45.66	7.02	5.27	1.76	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	100.58	47.15	9.43	0.00	3.14	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	75.80	48.68	6.95	3.48	1.39	2.09
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	77.46	55.33	11.07	4.43	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	55.11	68.08	6.48	3.24	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	74.99	54.93	6.10	3.49	2.62	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	69.74	58.49	9.00	2.25	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	66.21	55.75	3.48	6.97	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	67.21	82.14	5.33	3.20	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	72.04	40.18	5.54	4.16	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	108.28	48.44	19.95	0.00	2.85	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	81.92	60.75	8.28	0.92	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	57.48	45.38	9.08	3.03	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	136.59	80.71	0.00	6.21	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	63.44	77.19	12.69	3.17	0.00	0.00
Keratinocyte - epidermal, donor1	11272-116H3	58.59	23.17	51.82	1.06	2.53	0.00
Keratinocyte - epidermal, donor2	11349-117G8	103.66	28.70	46.85	2.93	1.76	0.00
Keratinocyte - epidermal, donor3	11421-118F8	84.43	18.74	17.04	1.99	0.76	0.09
Keratinocyte - oral, donor1	11251-116E9	71.86	29.51	4.20	0.11	0.00	0.00
Keratocytes, donor1	11527-119I6	73.24	80.11	43.67	9.28	1.72	0.34
Keratocytes, donor2	11607-120I5	87.89	35.15	35.15	8.20	1.17	0.00
Keratocytes, donor3	11688-122I5	62.24	52.36	16.40	3.95	0.00	0.20
Krukenberg tumor cell line:HSKTC	10687-109F3	24.18	4.40	0.00	0.00	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	61.49	26.97	1.08	3.24	0.00	0.00
Lens Epithelial Cells, donor2	11609-120I7	50.63	18.34	0.58	0.81	0.35	0.00
Lens Epithelial Cells, donor3	11690-122I7	46.82	25.63	1.61	1.11	0.30	0.20
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	61.07	15.18	5.10	8.30	0.95	0.12
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	64.75	13.67	6.42	6.98	0.00	0.28
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	63.59	14.80	5.35	4.41	0.79	0.31
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	75.82	13.44	7.53	5.91	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	64.92	20.49	6.30	3.15	0.32	0.63
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	69.97	14.45	5.93	5.71	0.86	0.75
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	68.54	14.36	2.46	5.34	0.41	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	82.42	18.20	9.10	6.83	0.76	0.51
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	63.62	17.17	5.35	7.32	0.99	0.84
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	52.61	14.63	4.75	3.96	0.40	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	61.46	16.87	4.07	7.56	1.16	0.58
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	87.02	15.00	6.67	8.70	0.56	0.37
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	62.02	19.16	6.27	8.71	1.05	0.70
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	67.50	16.94	4.05	7.63	0.48	0.48
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	64.28	13.32	6.32	4.94	1.10	0.27
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	60.05	13.55	4.62	7.08	0.92	0.31
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	69.52	11.85	4.36	6.23	0.31	0.31
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	73.75	18.30	5.86	6.77	1.10	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	77.34	12.84	3.95	7.90	0.00	0.99
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	77.61	14.64	5.86	5.56	0.59	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	84.64	19.42	7.47	6.72	1.00	0.75
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	64.02	16.00	3.39	8.73	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	66.79	16.70	4.58	4.85	0.27	0.27
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	63.88	12.41	5.00	6.06	0.00	0.61
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	77.76	18.66	7.26	5.18	0.00	0.52
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	61.77	14.66	4.40	6.70	0.21	0.42
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	68.72	14.59	6.17	7.22	1.05	0.45
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	61.22	9.63	6.19	6.19	0.00	1.38
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	63.59	12.23	3.76	7.34	0.75	0.19
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	71.04	11.77	5.09	5.83	1.38	0.53
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	66.87	11.15	5.33	8.72	0.97	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	57.89	12.90	2.98	4.96	0.33	0.33
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	68.64	15.49	6.19	6.19	0.74	0.62
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	72.19	12.22	3.33	7.40	1.48	0.37
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	64.74	12.11	2.72	5.44	0.49	0.49
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	73.28	14.71	5.22	6.05	0.55	0.27
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	64.33	11.58	5.15	7.72	0.32	1.93
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	57.52	12.17	3.35	3.65	0.61	0.61
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	64.24	13.58	3.22	6.44	0.84	0.56
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	75.38	11.38	4.27	6.76	1.07	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	67.87	18.42	5.33	5.33	0.00	0.48
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	78.27	16.34	5.76	6.85	0.62	0.31
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	74.13	13.25	5.37	7.88	1.07	0.36
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	63.37	14.05	5.23	4.57	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	83.10	15.54	5.89	6.12	0.24	0.24
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	52.97	12.62	4.95	6.19	0.99	0.25
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	47.90	13.83	5.12	6.40	0.51	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	61.16	11.93	3.28	8.35	0.90	0.30
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	31.72	18.13	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	53.70	25.32	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	51.21	19.30	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	60.51	28.35	0.00	0.00	0.42	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	49.94	23.91	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	67.25	20.55	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	47.92	19.06	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	51.15	23.79	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	69.44	29.18	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	54.09	23.56	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	53.12	18.01	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	60.02	27.91	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	65.22	29.27	0.51	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	52.22	25.76	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	56.64	20.66	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	53.99	21.39	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	48.03	16.81	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	58.20	21.92	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	65.65	29.45	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	61.97	23.65	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	54.77	23.12	0.21	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	50.17	24.94	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	60.79	21.64	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	59.80	19.45	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	53.21	20.63	0.30	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	49.24	16.60	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	54.44	22.98	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	46.84	25.81	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	74.83	27.63	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	57.56	20.72	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	47.55	17.55	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	63.18	17.23	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	65.52	23.50	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	52.42	26.57	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	59.01	26.89	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	56.11	22.30	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	49.54	35.32	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	54.80	23.98	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	69.30	25.65	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	51.28	21.12	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	68.97	18.49	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	69.77	20.62	0.34	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	56.90	28.98	0.54	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	47.14	22.22	0.00	0.00	0.67	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	61.12	20.74	0.37	0.00	0.74	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	40.70	25.58	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	62.41	24.33	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	62.42	27.61	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	68.33	29.07	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	69.75	24.53	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	60.67	26.64	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	51.75	19.76	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	69.39	23.13	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	63.99	27.04	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	30.98	17.21	1.72	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	59.68	22.27	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	62.96	23.07	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	55.42	22.43	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	56.56	28.02	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	52.07	23.63	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	49.20	26.84	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	56.53	19.87	0.44	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	60.56	23.91	0.00	0.00	0.39	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	54.69	26.84	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	64.88	18.26	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	69.57	24.25	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	52.86	24.91	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	56.03	20.06	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	58.90	24.32	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	49.06	22.72	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	47.16	15.72	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	61.48	23.45	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	55.44	25.06	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	52.87	20.11	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	58.11	20.57	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	53.05	24.76	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	55.05	32.35	0.57	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	54.92	24.96	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	66.56	25.84	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	57.20	22.97	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	57.15	23.23	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	57.54	25.42	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	55.60	26.73	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	74.76	25.86	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	34.87	22.03	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	62.24	24.90	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	55.85	20.52	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	56.75	19.17	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	51.43	20.25	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	59.24	19.15	0.00	0.00	0.45	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	60.83	26.26	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	76.92	24.53	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	68.59	45.73	0.00	0.00	0.00	0.00
Macrophage - monocyte derived, donor1	11232-116C8	82.51	31.68	92.99	16.41	10.71	0.46
Macrophage - monocyte derived, donor2	11313-117C8	65.88	20.55	53.58	18.35	7.16	2.94
Macrophage - monocyte derived, donor3	11389-118C3	71.57	23.20	60.69	17.17	7.73	2.10
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	108.86	20.18	40.36	5.84	3.19	0.53
Mallassez-derived cells, donor2	11929-125I3	74.95	16.80	8.56	0.48	0.32	0.16
Mallassez-derived cells, donor3	11930-125I4	72.97	17.65	14.04	1.39	0.97	0.00
Mammary Epithelial Cell, donor1	11273-116H4	70.85	30.79	4.88	0.20	0.40	0.00
Mammary Epithelial Cell, donor2	11350-117G9	66.89	26.35	5.21	0.29	0.00	0.00
Mammary Epithelial Cell, donor3	11422-118F9	104.51	29.43	0.75	0.00	0.00	0.00
Mast cell - stimulated, donor1	11487-119E2	16.95	6.10	2.71	2.03	2.03	0.00
Mast cell, donor1	11563-120D6	65.21	18.60	15.57	10.81	1.62	0.97
Mast cell, donor2	11565-120D8	74.59	16.64	56.76	22.59	6.54	0.89
Mast cell, donor3	11566-120D9	57.41	18.46	47.95	22.06	2.70	0.90
Mast cell, donor4	11567-120E1	80.31	15.96	70.74	21.98	6.56	1.24
Mast cell, expanded and stimulated, donor5	11940-126A5	62.10	31.38	18.74	9.09	1.22	0.78
Mast cell, expanded and stimulated, donor8	11942-126A7	91.05	20.43	17.51	8.76	1.75	0.58
Mast cell, expanded, donor5	11939-126A4	79.50	36.60	21.22	17.67	2.41	0.69
Mast cell, expanded, donor8	11941-126A6	70.46	20.25	13.05	8.70	0.67	0.17
Melanocyte - dark, donor1	11502-119F8	73.73	14.73	5.27	9.85	0.80	0.50
Melanocyte - dark, donor2	11582-120F7	69.56	25.96	10.38	3.81	0.35	0.00
Melanocyte - dark, donor3	11663-122F7	80.77	47.59	2.10	1.01	0.43	0.14
Melanocyte - light, donor1	11274-116H5	57.12	36.67	7.99	3.06	0.71	0.00
Melanocyte - light, donor2	11351-117H1	93.50	55.28	11.60	4.09	0.00	0.00
Melanocyte - light, donor3	11423-118G1	81.52	28.62	8.67	0.87	0.87	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	103.71	39.26	5.31	2.50	0.62	0.00
Melanocyte, donor2 (MC+2)	12739-135I3	96.55	26.63	11.83	4.30	0.27	0.00
Melanocyte, donor3 (MC+3)	12837-137B2	69.91	40.71	3.75	1.34	0.54	0.27
Meningeal Cells, donor1	11493-119E8	84.48	33.62	1.74	0.74	0.00	0.25
Meningeal Cells, donor2	11573-120E7	69.54	25.53	1.76	1.76	0.00	0.00
Meningeal Cells, donor3	11654-122E7	66.34	30.24	2.36	0.98	0.16	0.08
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	89.82	22.81	8.84	3.14	2.00	0.29
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	48.50	26.26	13.89	3.92	0.81	0.40
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	187.93	91.99	95.93	27.60	10.51	5.26
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	134.74	40.55	66.72	17.01	3.92	3.92
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	121.28	27.99	32.29	14.35	5.74	0.00
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	68.19	24.14	16.09	3.60	1.91	0.42
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	85.45	30.66	32.67	8.54	1.01	0.00
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	101.53	34.72	13.84	6.15	0.88	0.22
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	89.13	24.11	20.46	2.92	0.73	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	105.58	35.40	16.78	7.98	1.64	0.00
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	58.03	42.52	8.03	4.43	0.55	0.14
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	120.07	36.80	66.91	15.61	2.60	1.49
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	58.02	33.42	24.08	4.34	1.18	0.53
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	72.11	37.98	21.96	10.98	1.19	0.30
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	67.73	74.74	88.75	11.68	2.34	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	73.65	30.74	8.97	5.12	0.00	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	108.11	30.48	38.99	18.08	2.48	1.06
Mesenchymal stem cells - hepatic, donor0	11218-116B3	73.18	28.46	25.96	5.00	1.56	0.00
Mesenchymal stem cells - umbilical, donor0	11214-116A8	92.16	37.74	5.08	6.53	0.73	1.45
Mesothelial Cells, donor1	11247-116E5	58.34	22.01	56.75	9.28	3.98	0.80
Mesothelial Cells, donor2	12156-128G5	47.04	21.02	49.55	12.01	2.50	2.50
Mesothelial Cells, donor3	11402-118D7	48.92	13.08	51.45	10.55	5.06	1.59
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	41.86	18.90	24.31	9.45	4.05	2.70
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	83.24	21.43	35.71	15.52	5.17	3.45
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	66.55	14.43	50.65	15.02	4.71	3.53
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	44.94	10.37	17.29	17.29	0.00	3.46
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	72.53	21.39	35.64	10.54	3.41	1.55
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	57.67	15.14	38.58	15.56	3.94	2.28
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	71.80	25.48	18.53	11.58	2.32	6.95
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	76.33	19.02	32.03	14.26	4.75	2.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	62.84	20.02	34.91	17.22	4.65	2.79
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	19.47	38.93	38.93	19.47	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	67.47	16.46	30.48	9.35	3.45	2.44
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	72.07	17.82	39.20	11.88	5.15	2.38
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	68.41	17.10	0.00	17.10	0.00	17.10
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	67.26	28.32	54.87	14.16	2.65	0.88
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	85.11	25.08	59.27	17.86	6.08	4.56
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	60.53	18.42	21.05	5.26	0.00	1.32
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	74.28	16.98	38.20	10.61	5.09	1.27
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	47.88	14.73	23.02	8.29	0.92	2.76
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	67.36	16.10	24.14	7.75	2.98	1.19
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	45.27	11.74	11.74	8.38	1.68	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	101.85	101.85	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	66.74	15.81	38.14	8.03	4.27	1.25
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	56.80	11.88	33.99	8.56	3.09	3.09
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	47.55	18.25	16.03	4.98	1.11	2.21
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	69.76	15.66	38.45	11.51	4.60	2.07
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	49.43	11.36	31.34	11.15	5.68	1.68
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	48.92	12.84	26.70	7.75	4.48	1.83
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	69.30	15.88	43.12	9.23	5.15	1.72
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	44.46	8.00	24.67	10.45	2.67	2.45
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	51.59	10.32	0.00	20.64	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	56.07	13.14	29.13	8.10	1.97	1.53
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	36.50	8.11	13.18	9.63	1.01	1.52
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	48.05	19.88	11.60	9.94	1.66	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	57.35	13.32	26.36	10.33	3.81	2.45
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	45.58	10.00	26.17	9.12	3.82	1.76
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	43.61	8.72	9.81	13.08	0.00	1.09
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	74.49	15.38	40.85	11.05	6.25	1.92
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	58.43	13.61	42.02	11.61	3.60	4.00
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	47.99	12.34	5.48	10.97	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	77.09	14.52	39.55	12.51	5.51	2.50
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	161.68	26.95	107.79	26.95	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	42.81	2.04	2.04	10.19	2.04	2.04
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	77.95	9.63	33.72	7.88	3.94	2.19
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	44.15	12.14	8.83	8.83	3.31	4.41
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	49.95	9.61	10.25	6.40	0.64	1.92
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	76.11	10.16	27.52	8.68	2.73	1.74
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	44.54	6.26	11.83	9.05	2.09	2.09
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	50.83	6.63	13.26	13.26	0.00	2.21
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	66.32	11.62	25.98	8.55	2.39	0.34
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	42.89	7.88	10.94	9.19	2.63	2.63
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	42.26	11.72	9.94	5.68	2.13	0.36
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	84.73	13.19	21.32	7.29	3.65	1.12
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	54.45	9.98	13.72	14.13	1.66	2.91
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	41.37	11.07	9.32	10.49	0.58	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	66.67	12.97	17.19	7.84	4.22	0.90
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	64.70	13.36	26.71	15.86	3.34	2.92
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	50.53	0.00	14.44	7.22	0.00	7.22
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	49.87	6.46	11.08	3.69	0.92	0.92
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	56.91	13.66	20.49	11.95	2.85	3.98
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	48.36	10.23	14.51	6.22	2.90	1.11
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	59.09	11.66	16.07	7.26	3.89	1.81
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	60.91	9.01	14.16	11.15	2.14	3.43
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	40.02	10.16	5.72	7.62	0.00	2.54
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	48.04	11.48	9.07	3.74	1.07	1.33
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	59.57	9.58	17.96	9.28	0.90	2.39
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	36.02	9.46	10.59	4.66	1.41	1.27
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	74.85	11.78	20.07	7.96	1.59	1.59
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	60.15	13.71	17.91	13.71	1.77	3.10
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	54.98	13.65	17.44	7.20	2.28	1.52
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	56.25	11.93	12.78	5.40	1.42	0.57
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	72.27	16.96	27.53	14.50	2.21	2.95
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	41.71	8.47	5.87	3.26	1.30	0.65
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	52.34	13.23	7.35	5.00	1.76	0.59
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	60.55	12.40	20.47	9.80	1.44	1.15
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	35.86	8.24	11.13	3.71	1.65	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	57.77	11.02	10.12	6.55	2.98	0.30
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	150.68	30.14	75.34	22.60	0.00	3.77
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	80.20	44.56	69.51	21.39	5.35	1.78
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	95.61	33.51	58.49	15.77	7.23	0.99
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	113.61	38.92	85.21	21.04	13.68	4.21
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	118.61	34.20	100.03	16.21	8.90	2.77
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	114.55	40.05	86.61	13.04	6.52	2.79
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	94.26	29.67	108.90	19.53	7.14	1.50
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	109.47	30.10	88.69	19.98	7.46	3.73
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	77.81	29.29	51.01	14.25	5.66	1.47
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	77.36	32.42	71.46	15.47	3.68	1.47
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	90.51	28.58	53.50	9.53	8.79	0.37
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	80.89	24.89	76.22	3.11	12.44	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	27.26	12.83	13.36	3.74	0.53	0.53
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	54.09	15.46	42.50	15.46	3.86	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	107.05	39.39	67.67	26.26	7.07	2.02
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	28.67	11.38	21.93	4.22	3.79	0.42
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	8.17	6.81	2.72	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	6.99	3.81	5.09	1.27	0.64	0.64
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	4.86	1.62	1.62	1.62	0.81	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	3.02	3.02	1.51	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	39.97	0.00	5.71	11.42	0.00	5.71
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	6.52	29.36	3.26	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	42.77	14.26	14.26	14.26	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	0.00	12.55	0.00	0.00	12.55	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	98.45	34.04	70.02	6.68	5.60	1.72
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	94.07	36.58	70.55	4.18	1.57	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	109.47	39.38	28.03	6.01	3.34	0.67
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	72.21	23.37	15.44	4.59	0.83	0.42
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	55.14	44.30	11.79	1.71	1.71	0.19
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	87.77	36.70	3.19	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	82.95	23.80	10.20	3.40	2.04	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	3.68	5.51	1.84	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	75.75	32.65	13.81	5.02	0.84	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	105.29	34.87	26.50	6.51	2.79	0.93
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	82.15	28.91	10.54	2.97	1.08	0.00
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	58.66	36.58	5.89	1.26	0.21	0.21
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	0.00	22.27	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	102.75	56.09	39.71	4.96	3.97	0.50
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	37.08	25.71	12.45	3.25	1.89	0.27
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	84.55	45.79	27.43	6.57	2.04	0.45
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	79.53	34.46	11.59	2.94	1.14	0.49
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	63.42	30.07	7.65	1.46	0.36	0.36
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	71.61	46.15	12.20	3.18	1.06	0.00
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	79.84	42.02	26.41	8.40	1.80	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	23.30	21.00	9.85	1.97	1.31	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	68.79	29.43	16.26	4.23	1.79	0.65
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	59.62	27.34	8.29	2.47	1.23	0.18
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	70.32	35.16	11.25	4.22	0.70	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	76.31	33.10	35.86	10.11	1.38	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	90.62	34.71	18.96	8.35	2.25	1.29
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	22.42	20.35	7.59	1.72	3.10	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	2.53	15.17	5.06	2.53	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	49.68	28.74	9.36	2.67	1.11	0.45
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	60.97	29.64	11.01	3.81	0.42	0.85
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	46.52	35.84	29.43	4.51	4.03	0.24
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	106.88	42.50	37.34	6.01	2.15	0.86
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	18.06	36.11	9.03	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	93.64	48.98	25.32	6.33	1.67	1.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	57.26	25.70	10.82	0.45	1.80	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	65.87	34.52	24.60	1.98	0.40	0.79
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	102.15	35.29	38.07	11.14	3.71	1.86
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	59.78	24.59	37.84	6.43	4.54	0.38
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	77.23	36.50	25.74	4.56	2.28	0.65
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	76.70	36.17	15.25	2.18	1.31	0.87
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	47.04	18.54	7.24	2.26	0.90	1.36
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	94.36	29.10	31.75	4.41	1.76	0.88
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	92.41	46.54	43.21	5.32	4.65	0.66
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	92.26	34.23	26.79	7.44	2.48	0.99
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	74.27	29.86	28.71	6.51	1.53	3.06
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	100.71	68.35	45.97	4.84	3.93	0.60
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	50.84	28.51	8.18	1.11	0.66	0.44
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	52.86	35.92	23.04	3.39	2.03	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	5.11	5.11	5.11	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	112.79	34.75	42.07	8.54	4.88	1.83
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	54.45	24.23	27.70	5.35	1.57	1.26
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	81.11	37.83	22.09	5.15	1.21	0.30
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	71.20	37.97	20.57	3.96	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	23.81	24.94	19.27	0.00	1.13	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	10.12	20.23	10.12	0.00	0.00	0.00
Myoblast, donor1	11241-116D8	76.40	37.39	68.08	5.47	3.11	0.87
Myoblast, donor2	11322-117D8	93.98	40.28	28.96	7.10	2.69	0.38
Myoblast, donor3	11398-118D3	85.26	29.43	24.55	5.89	1.85	0.50
NK T cell leukemia cell line:KHYG-1	10777-110G3	26.41	35.61	0.00	0.00	0.00	0.00
Natural Killer Cells, donor1	11230-116C6	68.58	13.53	2.77	0.00	0.00	0.00
Natural Killer Cells, donor2	11311-117C6	62.12	12.36	0.00	0.00	0.00	0.00
Natural Killer Cells, donor3	11387-118C1	59.63	16.01	2.76	0.37	0.00	0.00
Neural stem cells, donor1	11275-116H6	28.67	25.41	0.36	1.09	0.00	0.00
Neural stem cells, donor2	11352-117H2	40.44	13.48	0.00	0.00	0.00	0.00
Neurons, donor1	11494-119E9	105.82	20.48	1.14	0.00	0.00	0.00
Neurons, donor2	11574-120E8	46.23	32.36	0.44	0.22	0.00	0.00
Neurons, donor3	11655-122E8	89.62	18.91	0.00	0.00	0.82	0.82
Neutrophils, donor1	11233-116C9	15.78	0.93	0.00	1.86	0.00	0.00
Neutrophils, donor2	11314-117C9	2.90	0.00	0.00	0.00	0.00	0.00
Neutrophils, donor3	11390-118C4	13.44	0.61	0.00	0.61	0.00	0.00
Nucleus Pulposus Cell, donor1	11252-116F1	44.29	40.37	13.77	3.80	1.42	0.47
Nucleus Pulposus Cell, donor2	11409-118E5	62.84	30.61	10.74	2.60	0.65	0.65
Nucleus Pulposus Cell, donor3	11462-119B4	73.80	39.91	10.63	7.42	0.60	0.20
Olfactory epithelial cells, donor1	11933-125I7	84.11	25.60	15.83	2.34	1.51	0.28
Olfactory epithelial cells, donor2	11934-125I8	91.04	32.13	38.94	2.89	3.18	0.29
Olfactory epithelial cells, donor3	11935-125I9	88.65	32.80	13.96	0.57	2.16	0.00
Olfactory epithelial cells, donor4	11936-126A1	88.83	33.31	37.60	2.63	3.70	0.49
Oligodendrocyte - precursors, donor1	11496-119F2	76.43	21.06	24.67	3.61	2.41	0.00
Osteoblast - differentiated, donor1	11276-116H7	87.20	58.92	49.77	6.17	2.77	0.43
Osteoblast - differentiated, donor2	11353-117H3	90.31	61.73	83.45	13.72	1.14	4.57
Osteoblast - differentiated, donor3	11425-118G3	72.62	40.35	57.11	6.83	1.86	1.24
Osteoblast, donor1	11277-116H8	143.06	51.79	11.34	6.64	0.59	0.20
Osteoblast, donor2	11354-117H4	93.41	26.69	9.13	0.70	0.70	0.70
Osteoblast, donor3	11426-118G4	122.81	32.17	18.84	6.22	1.07	0.53
Pancreatic stromal cells, donor1	11249-116E7	55.01	38.58	26.79	3.20	1.43	0.08
Pericytes, donor1	11491-119E6	108.82	48.07	4.67	3.34	0.56	0.33
Pericytes, donor2	11571-120E5	112.28	38.26	5.43	2.26	1.13	0.68
Pericytes, donor3	11652-122E5	113.53	34.38	33.77	6.31	2.03	0.41
Perineurial Cells, donor1	11499-119F5	74.59	28.03	3.84	2.15	0.57	0.11
Perineurial Cells, donor2	11579-120F4	57.41	20.24	6.90	4.51	0.74	0.18
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	53.23	20.08	22.95	4.78	1.27	0.00
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	57.30	14.69	31.10	3.43	0.49	0.24
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	65.35	14.62	19.28	2.46	1.04	0.13
Placental Epithelial Cells, donor1	11278-116H9	283.17	68.88	4.78	0.24	0.72	0.00
Placental Epithelial Cells, donor2	11355-117H5	156.35	29.94	2.22	1.11	0.00	0.00
Placental Epithelial Cells, donor3	11427-118G5	147.44	19.04	2.94	0.20	0.20	0.20
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	97.78	26.90	51.58	11.08	4.11	1.90
Preadipocyte - breast, donor1	11467-119B9	67.91	35.83	61.34	3.75	1.69	1.13
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	145.93	35.50	131.70	9.53	10.18	0.78
Preadipocyte - breast, donor2	11328-117E5	99.07	34.45	78.13	8.33	3.15	0.90
Preadipocyte - omental, donor1	11468-119C1	75.87	38.57	52.85	5.01	2.77	0.64
Preadipocyte - omental, donor2	11329-117E6	76.38	35.35	55.87	6.11	2.62	0.87
Preadipocyte - omental, donor3	11403-118D8	79.65	24.93	39.68	7.02	2.15	0.57
Preadipocyte - perirenal, donor1	11469-119C2	122.05	25.59	25.59	11.81	0.98	0.98
Preadipocyte - subcutaneous, donor1	11279-116I1	88.14	30.71	54.05	19.66	3.38	1.84
Preadipocyte - subcutaneous, donor2	11356-117H6	94.38	25.68	44.98	15.94	1.42	1.06
Preadipocyte - subcutaneous, donor3	11428-118G6	113.24	36.10	57.56	16.86	3.58	1.36
Preadipocyte - visceral, donor1	11280-116I2	71.35	32.69	58.87	9.59	2.89	1.02
Preadipocyte - visceral, donor2	11357-117H7	71.33	25.77	41.88	10.58	0.46	1.84
Preadipocyte - visceral, donor3	11429-118G7	110.34	28.21	56.01	13.17	2.72	2.30
Prostate Epithelial Cells (polarized), donor1	11253-116F2	33.79	41.33	0.00	0.00	0.00	0.00
Prostate Epithelial Cells, donor2	11331-117E8	55.52	17.20	5.69	0.27	0.41	0.00
Prostate Epithelial Cells, donor3	11404-118D9	64.67	34.72	15.00	0.43	0.43	0.00
Prostate Stromal Cells, donor1	11254-116F3	38.16	21.75	10.02	1.25	0.34	0.23
Prostate Stromal Cells, donor2	11332-117E9	90.55	36.04	21.52	4.66	1.08	0.36
Prostate Stromal Cells, donor3	11405-118E1	71.53	29.82	21.27	5.42	1.88	0.42
Renal Cortical Epithelial Cells, donor1	11516-119H4	85.41	25.91	1.09	2.55	0.36	0.00
Renal Cortical Epithelial Cells, donor2	11596-120H3	55.24	17.19	0.83	0.55	0.00	0.00
Renal Epithelial Cells, donor1	11517-119H5	113.11	29.93	4.06	2.54	0.00	0.00
Renal Epithelial Cells, donor2	11597-120H4	96.03	14.94	7.82	1.42	0.71	0.00
Renal Epithelial Cells, donor3	11678-122H4	56.21	17.89	1.16	0.95	0.11	0.11
Renal Glomerular Endothelial Cells, donor1	11514-119H2	86.47	20.43	4.09	6.13	0.00	0.68
Renal Glomerular Endothelial Cells, donor2	11594-120H1	79.11	16.85	4.18	3.37	0.00	0.00
Renal Glomerular Endothelial Cells, donor3	11675-122H1	72.38	23.31	3.33	1.78	0.44	0.44
Renal Glomerular Endothelial Cells, donor4	11783-124B1	89.17	28.61	2.66	2.66	0.00	0.00
Renal Mesangial Cells, donor1	11518-119H6	91.12	33.67	5.06	2.42	0.00	0.44
Renal Mesangial Cells, donor2	11598-120H5	114.11	23.20	5.64	3.13	0.63	0.00
Renal Mesangial Cells, donor3	11679-122H5	115.13	29.68	8.04	4.99	0.28	0.55
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	91.80	27.38	3.22	0.81	0.00	0.27
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	75.06	25.72	2.53	1.27	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	94.30	17.55	4.63	1.54	1.16	0.77
Retinal Pigment Epithelial Cells, donor0	11215-116A9	64.56	31.11	4.41	3.11	0.52	0.00
Retinal Pigment Epithelial Cells, donor1	11528-119I7	63.95	36.10	13.93	6.25	1.99	0.28
Retinal Pigment Epithelial Cells, donor2	11608-120I6	66.89	12.35	8.23	1.03	1.03	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	80.79	52.19	31.87	2.51	1.00	0.00
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	56.13	29.27	4.54	1.20	0.27	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	28.59	35.74	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	34.67	56.14	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	15.66	33.06	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	36.80	28.09	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	49.35	25.82	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	51.53	38.03	0.11	0.00	0.00	0.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	46.27	24.93	0.12	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	51.98	28.44	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	51.77	30.28	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	46.82	21.63	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	48.86	23.60	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	58.24	33.69	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	47.34	25.82	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	53.76	28.55	0.21	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	58.19	27.88	0.22	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	47.60	24.28	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	50.49	22.82	0.09	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	37.58	30.63	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	47.77	20.97	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	45.85	23.36	0.10	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	56.52	30.55	0.38	0.19	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	50.62	21.04	0.21	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	47.09	30.83	0.28	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	40.50	31.45	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	48.32	27.35	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	48.56	24.89	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	61.12	30.22	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	59.91	34.44	0.24	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	60.91	24.01	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	60.57	35.78	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	63.45	25.30	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	52.65	28.98	0.22	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	44.91	28.62	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	53.43	26.38	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	54.66	26.23	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	49.36	29.30	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	53.64	26.13	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	47.87	21.67	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	55.98	33.16	0.33	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	44.14	23.86	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	52.67	24.71	0.44	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	40.25	24.26	0.27	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	50.61	32.49	0.28	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	59.05	26.43	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	36.68	26.40	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	45.20	25.99	0.38	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	58.34	34.94	0.35	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	45.94	33.24	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	55.20	25.33	0.12	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	57.06	53.56	2.04	0.00	0.15	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	65.71	52.93	1.22	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	59.98	28.63	0.30	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	68.54	49.08	6.33	0.00	0.23	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	58.71	43.73	4.49	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	67.66	43.45	5.67	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	75.99	39.70	14.51	0.21	0.21	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	54.09	55.29	4.81	0.00	0.00	0.60
Schwann Cells, donor1	11498-119F4	152.90	39.31	3.39	6.02	0.56	0.38
Schwann Cells, donor2	11578-120F3	112.28	34.02	6.80	3.40	0.00	3.40
Schwann Cells, donor3	11659-122F3	113.70	35.93	1.53	1.53	1.10	0.00
Sebocyte, donor1	11220-116B5	41.63	18.08	11.50	1.10	0.55	0.00
Sebocyte, donor2	11301-117B5	34.93	15.62	36.30	2.30	2.30	0.00
Sebocyte, donor3	11378-118B1	63.89	31.33	40.19	2.89	2.27	0.00
Sertoli Cells, donor1	11255-116F4	74.55	21.54	48.04	6.63	0.00	3.31
Sertoli Cells, donor2	11333-117F1	87.56	48.01	56.49	5.65	0.00	0.00
Skeletal Muscle Cells, donor1	11281-116I3	108.83	68.53	32.20	3.78	3.08	0.26
Skeletal Muscle Cells, donor2	11358-117H8	109.15	64.33	41.20	6.51	6.51	1.45
Skeletal Muscle Cells, donor3	11430-118G8	237.43	51.00	15.05	3.34	0.00	0.00
Skeletal Muscle Cells, donor4	11451-119A2	92.37	25.29	16.97	7.38	0.47	1.10
Skeletal Muscle Cells, donor5	11455-119A6	85.02	24.38	15.31	6.54	0.89	0.89
Skeletal Muscle Cells, donor6	11459-119B1	95.73	24.01	8.62	5.39	1.08	0.92
Skeletal Muscle Satellite Cells, donor1	11240-116D7	48.76	37.05	13.73	5.17	1.51	0.25
Skeletal Muscle Satellite Cells, donor2	11321-117D7	62.35	25.26	13.13	7.71	1.43	0.71
Skeletal Muscle Satellite Cells, donor3	11397-118D2	75.80	19.25	9.23	6.85	0.69	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	58.72	42.38	17.36	2.36	2.11	0.42
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	156.33	70.21	18.09	2.90	2.90	0.72
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	130.58	25.59	10.87	4.82	0.55	0.83
Skin - palm, donor1	10286-104F7	69.84	26.86	21.49	5.37	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	67.03	24.07	6.49	0.58	0.72	0.00
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	91.60	38.44	15.54	0.00	0.00	0.00
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	82.57	18.95	8.96	0.52	0.91	0.00
Small Airway Epithelial Cells, donor1	11256-116F5	64.64	24.47	11.68	0.83	0.14	0.28
Small Airway Epithelial Cells, donor2	11334-117F2	64.56	12.66	10.13	1.83	0.42	0.14
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	77.81	17.97	11.63	0.00	0.63	0.00
Small Airway Epithelial Cells, donor3	11406-118E2	70.68	16.79	19.79	1.42	1.35	0.22
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	80.85	33.64	56.16	5.86	1.23	1.85
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	64.70	16.01	62.25	1.78	2.45	0.44
Smooth Muscle Cells - Aortic, donor0	11210-116A4	95.23	27.04	38.80	8.82	1.76	0.00
Smooth Muscle Cells - Aortic, donor1	11283-116I5	74.25	20.55	38.89	6.85	3.09	0.44
Smooth Muscle Cells - Aortic, donor2	11360-117I1	98.45	37.41	46.47	12.60	3.54	0.79
Smooth Muscle Cells - Aortic, donor3	11432-118H1	100.43	30.90	38.63	13.91	2.32	2.32
Smooth Muscle Cells - Bladder, donor1	11519-119H7	62.05	43.03	7.01	2.00	0.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	82.64	20.89	27.15	8.65	3.46	0.67
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	84.23	24.83	37.68	3.77	3.32	0.00
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	77.46	19.59	24.33	5.25	0.38	0.64
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	70.98	35.81	7.16	3.26	0.65	0.00
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	64.38	29.53	14.77	2.36	1.18	0.30
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	59.94	18.51	48.69	7.40	2.99	0.71
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	96.95	43.11	25.54	8.95	2.44	0.49
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	68.80	57.84	87.37	7.00	5.78	1.22
Smooth Muscle Cells - Carotid, donor1	11285-116I7	122.24	39.40	59.35	14.40	6.06	0.25
Smooth Muscle Cells - Carotid, donor2	11362-117I3	79.57	18.36	12.24	6.12	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	107.29	19.07	23.84	9.06	1.43	1.43
Smooth Muscle Cells - Colonic, donor1	11239-116D6	57.66	28.46	12.24	1.62	1.18	0.59
Smooth Muscle Cells - Colonic, donor2	11320-117D6	57.90	26.47	8.18	3.01	0.65	0.43
Smooth Muscle Cells - Colonic, donor3	11396-118D1	61.09	22.46	8.19	3.25	0.42	0.10
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	94.20	23.98	53.98	13.30	4.02	0.62
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	117.49	22.64	44.19	8.62	4.31	1.08
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	87.56	28.39	16.74	7.47	1.49	0.90
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	95.59	50.19	13.66	3.76	1.02	0.34
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	39.42	40.05	11.62	2.12	1.41	0.31
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	47.91	36.43	29.59	3.22	3.12	0.30
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	76.46	22.30	26.17	7.05	1.37	0.91
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	141.90	22.94	20.53	12.08	1.81	0.60
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	65.44	22.78	5.83	1.32	0.26	0.26
Smooth Muscle Cells - Prostate, donor1	11257-116F6	70.97	22.24	13.98	3.86	0.80	0.80
Smooth Muscle Cells - Prostate, donor2	11335-117F3	57.10	25.29	21.91	5.26	1.13	0.63
Smooth Muscle Cells - Prostate, donor3	11465-119B7	72.55	35.01	36.53	4.31	1.27	0.76
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	112.93	33.77	54.88	12.97	3.32	1.36
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	108.77	37.51	66.01	16.50	6.75	2.25
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	67.20	9.05	3.88	3.88	0.00	1.29
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	123.71	34.42	34.42	11.16	2.33	0.93
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	94.92	24.74	38.88	6.56	4.54	1.01
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	89.94	17.55	31.34	5.01	1.88	0.63
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	66.96	43.95	18.88	3.83	1.47	0.29
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	68.64	27.32	7.91	3.17	0.58	0.67
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	62.60	32.23	25.69	9.81	2.34	0.00
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	73.54	20.72	9.64	2.16	0.58	0.14
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	97.90	21.67	13.77	2.55	1.27	0.51
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	115.64	24.82	9.97	4.14	0.38	0.19
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	61.91	27.53	7.69	1.82	1.26	0.00
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	90.41	34.44	24.72	8.21	2.18	0.59
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	135.71	49.52	10.00	2.38	0.00	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	76.09	18.35	7.10	3.18	0.98	0.24
Smooth Muscle Cells - Uterine, donor1	11258-116F7	54.57	23.64	24.30	9.06	0.22	0.44
Smooth Muscle Cells - Uterine, donor3	11466-119B8	94.50	34.52	64.66	8.78	6.14	0.88
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	52.67	36.93	50.92	5.25	1.94	1.17
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	65.85	58.18	58.71	3.97	2.12	0.53
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	31.62	38.31	88.52	5.58	7.81	0.37
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	60.01	48.51	52.82	2.87	1.80	0.36
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	82.90	50.82	16.47	2.27	0.85	0.28
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	94.53	29.93	33.08	4.33	1.18	0.79
Smooth muscle cells - airway, control, donor1	11966-126D4	35.81	34.54	44.70	2.79	2.54	0.25
Smooth muscle cells - airway, control, donor2	11967-126D5	34.74	30.35	41.53	2.80	3.59	0.40
Smooth muscle cells - airway, control, donor3	11968-126D6	59.77	51.00	63.95	6.69	2.93	0.84
Smooth muscle cells - airway, control, donor4	11969-126D7	90.30	57.75	82.50	7.33	6.42	1.38
Synoviocyte, donor1	11291-117A4	80.79	17.51	16.83	1.18	1.85	0.00
Synoviocyte, donor2	11368-117I9	63.53	30.51	72.08	10.90	3.35	1.34
Synoviocyte, donor3	11440-118H9	75.07	34.18	48.26	6.26	3.35	2.01
Trabecular Meshwork Cells, donor1	11532-120A2	99.34	35.73	7.15	1.43	1.07	0.00
Trabecular Meshwork Cells, donor2	11612-122A1	89.19	57.48	91.17	9.91	5.95	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	86.37	28.71	17.37	5.09	1.62	0.00
Tracheal Epithelial Cells, donor1	11292-117A5	79.35	24.23	10.97	0.72	0.72	0.00
Tracheal Epithelial Cells, donor2	11369-118A1	93.16	16.24	18.94	2.71	2.32	0.39
Tracheal Epithelial Cells, donor3	11441-118I1	94.49	16.03	10.31	1.15	0.57	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	54.50	33.09	4.55	0.98	0.62	0.12
Urethra, donor2	10319-105A4	71.94	23.38	0.00	0.00	0.00	0.00
Urothelial Cells, donor1	11520-119H8	64.02	24.18	0.27	0.00	0.00	0.00
Urothelial Cells, donor2	11600-120H7	71.30	23.23	1.60	0.00	0.40	0.00
Urothelial Cells, donor3	11681-122H7	93.74	25.21	0.69	0.00	0.00	0.00
Urothelial cells, donor0	11216-116B1	67.31	23.18	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090309, donation1	12179-129A1	50.72	16.02	8.90	2.67	1.78	0.89
Whole blood (ribopure), donor090309, donation2	12180-129A2	50.04	15.73	12.87	4.29	0.00	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	34.91	17.80	8.21	2.05	0.00	0.00
Whole blood (ribopure), donor090325, donation1	12176-128I7	33.06	21.69	14.81	3.10	0.34	0.34
Whole blood (ribopure), donor090325, donation2	12177-128I8	30.21	24.98	16.85	2.91	1.16	0.00
Whole blood (ribopure), donor090612, donation1	12182-129A4	44.77	21.87	5.21	4.16	0.00	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	51.40	19.27	4.59	1.84	0.00	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	35.60	15.52	17.35	0.00	0.00	0.00
Wilms' tumor cell line:G-401	10809-111A8	25.04	26.28	0.00	0.00	0.00	0.00
Wilms' tumor cell line:HFWT	10597-108E3	71.28	51.92	0.88	0.00	0.00	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	40.78	15.64	0.00	0.00	0.00	0.00
achilles tendon, donor2	10292-104G4	53.73	16.53	10.33	4.13	0.00	2.07
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	14.79	20.65	2.04	1.78	0.25	0.00
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	26.70	30.88	0.00	0.00	0.00	0.00
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	18.87	25.28	0.00	0.00	0.00	0.00
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	36.74	51.43	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	28.67	53.12	0.28	0.00	0.00	0.00
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	54.99	50.76	0.42	0.00	0.00	0.00
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	11.98	8.17	10.89	2.99	0.54	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	89.01	85.48	45.39	7.05	5.29	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	31.44	31.85	20.01	10.21	0.82	0.00
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	75.33	28.73	43.88	9.32	3.49	0.39
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	26.50	27.97	16.93	1.84	0.74	0.00
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	42.91	15.60	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	37.41	44.38	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	73.27	35.21	36.25	3.11	1.04	0.26
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	65.46	35.36	50.85	7.01	3.80	0.88
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	28.82	14.87	30.21	5.58	1.39	0.46
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	24.68	61.69	0.00	0.00	0.41	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	36.83	39.90	136.29	28.55	11.36	2.46
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	43.52	34.56	119.91	22.19	6.83	2.13
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	51.26	41.85	140.12	16.98	13.34	0.91
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	44.77	35.62	123.96	20.22	8.67	1.68
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	40.76	35.19	63.48	3.56	4.01	0.00
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	35.69	17.34	3.67	1.33	0.33	0.00
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	24.16	57.60	1.86	0.00	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	52.73	47.08	11.68	2.26	0.00	0.00
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	27.91	29.66	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	29.99	13.12	1.87	3.75	0.00	0.00
adenocarcinoma cell line:IM95m	10796-110I4	45.92	20.02	0.24	0.00	0.00	0.00
adipose tissue, adult, pool1	10010-101C1	64.53	26.22	23.89	3.88	1.40	0.31
adipose, donor1	10184-103D4	12.31	8.80	0.00	0.00	0.00	0.00
adipose, donor2	10185-103D5	42.98	12.98	0.00	0.00	0.00	0.00
adipose, donor3	10186-103D6	43.84	15.25	0.27	0.00	0.00	0.00
adipose, donor4	10187-103D7	19.07	19.94	0.00	0.00	0.00	0.00
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	36.46	40.72	0.00	0.00	0.00	0.00
adrenal gland, adult, pool1	10081-102A9	65.48	29.10	7.28	0.00	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	40.16	31.08	23.08	0.80	1.47	0.00
alveolar cell carcinoma cell line:SW 1573	10708-109H6	68.60	52.88	0.00	0.00	0.00	0.00
amniotic membrane cells, donor1	12235-129G3	114.07	14.37	10.90	0.00	0.46	0.00
amniotic membrane cells, donor2	12236-129G4	146.06	19.95	5.07	0.68	0.34	0.00
amniotic membrane cells, donor3	12237-129G5	104.29	15.32	4.42	0.00	0.00	0.00
amygdala - adult, donor10196	10167-103B5	28.46	43.87	0.00	0.00	0.00	0.00
amygdala, adult, donor10252	10151-102I7	45.42	39.74	0.61	0.81	0.00	0.00
amygdala, newborn, donor10223	10360-105E9	23.24	32.92	2.58	0.00	0.00	0.00
anaplastic carcinoma cell line:8305C	10428-106D5	44.18	49.40	0.00	0.00	0.13	0.00
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	45.45	22.50	1.10	0.44	0.00	0.00
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	48.44	24.38	0.00	0.00	0.00	0.00
aorta, adult, pool1	10052-101G7	74.14	19.42	10.20	3.73	0.78	0.20
appendix, adult	10189-103D9	54.72	18.63	5.82	2.33	0.39	0.39
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	16.85	37.83	0.00	0.00	0.00	0.00
artery, adult	10190-103E1	74.73	12.23	6.79	1.36	0.00	0.00
astrocytoma cell line:TM-31	10425-106D2	21.87	28.10	0.00	0.00	0.00	0.00
b cell line:RPMI1788	10427-106D4	20.22	31.97	2.08	2.38	0.15	0.15
basal cell carcinoma cell line:TE 354.T	10702-109G9	125.68	34.68	95.44	8.88	7.77	1.94
bile duct carcinoma cell line:HuCCT1	10432-106D9	45.94	21.14	0.30	0.00	0.00	0.00
bile duct carcinoma cell line:TFK-1	10496-107C1	14.56	32.14	0.00	0.00	0.00	0.00
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	93.39	39.15	129.74	10.63	5.59	0.00
bladder, adult, pool1	10011-101C2	65.18	34.11	13.91	1.41	0.54	0.11
blood, adult, pool1	10053-101G8	31.00	15.50	13.29	2.21	0.00	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	38.54	15.41	7.71	1.71	0.86	0.00
bone marrow, adult	10192-103E3	49.94	29.02	6.07	2.02	0.00	0.00
brain, adult, donor1	10084-102B3	57.40	41.00	11.28	0.00	1.03	0.00
brain, adult, pool1	10012-101C3	38.98	60.47	9.13	1.78	0.56	0.11
brain, fetal, pool1	10085-102B4	42.74	53.43	0.00	0.00	0.00	0.00
breast carcinoma cell line:MCF7	10482-107A5	35.35	16.52	0.00	0.00	0.00	0.00
breast carcinoma cell line:MDA-MB-453	10419-106C5	80.26	22.84	1.25	0.00	0.12	0.00
breast, adult, donor1	10080-102A8	111.75	19.57	16.42	1.89	2.53	0.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	92.86	56.28	0.00	0.00	0.13	0.00
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	33.09	15.77	0.00	0.00	0.00	0.00
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	36.37	41.44	0.00	0.00	0.00	0.00
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	29.29	11.38	0.48	0.00	0.00	0.00
carcinoid cell line:NCI-H1770	10703-109H1	25.39	39.96	0.00	0.00	0.00	0.00
carcinoid cell line:NCI-H727	10735-110B6	21.22	29.10	0.00	0.00	0.00	0.00
carcinoid cell line:SK-PN-DW	10719-109I8	27.57	22.50	0.00	0.00	0.00	0.00
carcinosarcoma cell line:JHUCS-1	10642-109A3	43.92	21.83	0.00	0.00	0.00	0.00
caudate nucleus - adult, donor10196	10177-103C6	33.39	63.32	4.61	1.15	0.00	0.00
caudate nucleus, adult, donor10252	10164-103B2	43.17	43.50	1.00	0.67	0.00	0.00
caudate nucleus, adult, donor10258	10379-105H1	26.74	67.24	0.76	0.00	0.00	0.00
caudate nucleus, newborn, donor10223	10354-105E3	28.93	36.99	0.73	0.00	0.00	0.00
cerebellum - adult, donor10196	10173-103C2	40.79	49.53	5.83	0.00	0.00	0.00
cerebellum, adult, donor10252	10166-103B4	39.50	35.23	2.14	0.43	0.00	0.00
cerebellum, adult, pool1	10083-102B2	38.29	33.46	8.28	4.14	0.00	0.00
cerebellum, newborn, donor10223	10357-105E6	19.93	22.42	1.66	0.83	0.00	0.00
cerebral meninges, adult	10188-103D8	46.65	44.38	2.52	0.76	0.25	0.00
cerebrospinal fluid, donor2	10294-104G6	43.85	21.93	2.92	1.46	0.00	0.00
cervical cancer cell line:D98-AH2	10552-107I3	53.34	99.07	22.86	0.43	0.86	0.00
cervical cancer cell line:ME-180	10553-107I4	82.69	31.15	0.00	0.00	0.00	0.00
cervix, adult, pool1	10013-101C4	76.85	35.28	21.94	1.47	1.47	0.31
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	81.10	38.60	0.00	0.00	0.00	0.00
chondrosarcoma cell line:SW 1353	10700-109G7	28.74	15.68	0.00	0.00	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	35.67	37.66	0.00	0.00	0.00	0.00
choriocarcinoma cell line:SCH	10785-110H2	34.50	31.30	0.12	0.00	0.00	0.00
choriocarcinoma cell line:T3M-3	10618-108G6	18.03	20.63	0.00	0.00	0.00	0.00
chorionic membrane cells, donor1	12238-129G6	84.34	19.66	5.41	0.85	0.85	0.00
chorionic membrane cells, donor2	12239-129G7	86.21	25.35	14.82	5.77	0.99	0.10
chorionic membrane cells, donor3	12240-129G8	66.49	22.53	2.75	1.10	0.00	0.00
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	44.43	34.33	0.00	0.00	0.00	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	43.22	20.55	8.26	3.07	0.58	0.00
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	55.33	42.66	84.26	16.26	5.07	0.63
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	37.75	33.64	3.34	0.51	0.77	0.26
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	38.94	31.69	4.35	1.21	0.00	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	39.50	28.91	2.85	1.02	0.00	0.00
chronic myelogenous leukemia cell line:K562	10454-106G4	47.11	34.45	4.42	0.88	0.29	0.29
chronic myelogenous leukemia cell line:KU812	10409-106B4	50.82	46.13	56.56	5.73	3.13	0.52
clear cell carcinoma cell line:JHOC-5	10638-108I8	46.40	27.66	0.00	0.00	0.00	0.00
clear cell carcinoma cell line:TEN	10636-108I6	46.50	56.39	0.35	0.00	0.00	0.00
colon carcinoma cell line:CACO-2	10513-107D9	38.07	34.59	0.00	0.00	0.00	0.00
colon carcinoma cell line:COLO-320	10420-106C6	13.68	46.75	0.00	0.00	0.00	0.00
colon, adult, donor1	10082-102B1	72.59	19.04	3.57	0.00	0.00	0.00
colon, adult, pool1	10014-101C5	73.67	26.20	8.34	2.12	0.47	0.12
colon, fetal, donor1	10070-101I7	37.08	17.30	4.33	1.24	0.00	0.00
common myeloid progenitor CMP, donor1	12130-128D6	59.59	27.50	0.00	4.58	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	125.18	25.04	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	24.22	39.09	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection	10453-106G3	33.20	36.83	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a untreated	10449-106F8	35.68	33.70	0.00	0.00	0.00	0.00
corpus callosum, adult, pool1	10042-101F6	88.56	76.84	34.05	7.30	2.10	0.77
cruciate ligament, donor2	10295-104G7	67.27	19.45	8.92	0.00	0.81	0.00
diaphragm, fetal, donor1	10069-101I6	72.23	12.84	12.04	1.61	0.80	0.00
diencephalon, adult	10193-103E4	72.00	41.76	26.64	3.12	1.20	0.24
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	35.59	26.86	0.00	0.00	0.00	0.00
ductal cell carcinoma cell line:KLM-1	10438-106E6	17.95	14.36	0.00	0.00	0.00	0.00
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	47.90	55.37	19.26	0.48	0.72	0.00
ductus deferens, adult	10196-103E7	70.76	20.93	3.99	0.00	0.50	0.00
duodenum, fetal, donor1, tech_rep1	10071-101I8	56.17	12.96	8.64	1.44	0.00	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	52.97	23.54	1.47	0.00	0.00	0.00
dura mater, adult, donor1	10041-101F5	59.22	19.41	21.31	3.47	1.57	0.33
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	22.65	119.03	0.44	0.00	0.00	0.00
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	44.28	74.37	0.14	0.00	0.00	0.00
embryonic pancreas cell line:1B2C6	10604-108F1	37.61	21.58	0.00	0.00	0.00	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	43.89	41.47	0.00	0.00	0.00	0.00
embryonic pancreas cell line:1C3IKEI	10606-108F3	42.61	27.48	0.00	0.00	0.00	0.00
embryonic pancreas cell line:2C6	10603-108E9	45.97	38.09	0.00	0.00	0.00	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	19.11	33.18	0.00	0.00	0.00	0.00
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	92.25	94.24	0.36	0.00	0.18	0.00
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	38.43	17.85	0.00	0.00	0.00	0.00
epidermoid carcinoma cell line:A431	10426-106D3	44.35	34.57	0.00	0.00	0.00	0.00
epidermoid carcinoma cell line:Ca Ski	10431-106D8	38.71	20.79	0.00	0.00	0.00	0.00
epididymis, adult	10197-103E8	88.54	22.40	12.14	2.51	0.21	0.21
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	71.85	70.79	0.18	0.00	0.00	0.00
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	45.62	48.37	0.00	0.00	0.00	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	33.16	33.16	0.13	0.00	0.00	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	22.93	29.62	0.10	0.00	0.00	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	30.58	37.53	0.11	0.00	0.00	0.00
esophagus, adult, pool1	10015-101C6	91.95	35.99	25.80	1.38	0.96	0.00
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	42.96	73.01	0.13	0.13	0.00	0.00
eye - muscle inferior rectus, donor1	10272-104E2	53.12	21.73	2.41	2.41	0.00	0.00
eye - muscle lateral, donor2	10298-104H1	35.77	16.83	0.00	0.00	0.00	0.00
eye - muscle medial, donor2	10299-104H2	47.62	17.86	0.00	2.98	0.00	0.00
eye - muscle superior, donor2	10297-104G9	63.06	34.39	2.29	0.00	0.00	0.00
eye - vitreous humor, donor1	10268-104D7	32.06	13.12	5.83	1.46	0.00	0.00
eye, fetal, donor1	10054-101G9	66.36	26.69	9.15	0.51	0.00	0.51
fibrosarcoma cell line:HT-1080	10758-110E2	41.42	62.83	0.13	0.00	0.00	0.00
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	64.10	54.84	0.24	0.00	0.00	0.00
frontal lobe, adult, pool1	10040-101F4	28.99	36.50	4.69	1.31	0.19	0.00
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	61.85	28.82	0.00	0.00	0.00	0.00
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	27.71	49.47	0.00	0.00	0.00	0.00
gall bladder, adult	10198-103E9	72.91	31.14	9.42	1.45	0.24	0.00
gamma delta positive T cells, donor1	11937-126A2	83.21	40.80	3.22	0.00	1.07	0.00
gamma delta positive T cells, donor2	11938-126A3	75.45	21.29	15.69	0.75	0.37	0.00
gastric adenocarcinoma cell line:MKN1	10614-108G2	97.37	36.75	0.00	0.00	0.00	0.00
gastric adenocarcinoma cell line:MKN45	10612-108F9	19.15	13.54	0.00	0.00	0.00	0.00
gastric cancer cell line:AZ521	10549-107H9	23.61	40.50	0.00	0.00	0.00	0.00
gastric cancer cell line:GSS	10560-108A2	58.57	76.88	0.92	0.00	0.00	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	28.79	43.18	0.46	0.46	0.00	0.00
giant cell carcinoma cell line:LU65	10487-107B1	36.95	47.85	0.11	0.00	0.00	0.00
giant cell carcinoma cell line:Lu99B	10433-106E1	31.35	13.58	8.12	1.96	0.00	0.28
glassy cell carcinoma cell line:HOKUG	10688-109F4	71.33	17.71	5.99	0.75	0.75	0.25
glioblastoma cell line:A172, tech_rep1	10444-106F3	53.09	23.54	0.00	0.00	0.00	0.00
glioblastoma cell line:A172, tech_rep2	10444-106F3	55.19	25.42	0.00	0.00	0.00	0.00
glioblastoma cell line:T98G	10485-107A8	80.90	69.54	1.10	0.11	0.00	0.00
glioma cell line:GI-1	10413-106B8	24.31	32.22	0.00	0.00	0.00	0.00
globus pallidus - adult, donor10196	10175-103C4	53.94	63.42	4.37	5.10	0.73	0.73
globus pallidus, adult, donor10252	10161-103A8	76.16	66.88	4.64	2.93	0.73	0.00
globus pallidus, adult, donor10258	10367-105F7	58.88	102.69	24.65	4.11	1.37	2.74
globus pallidus, newborn, donor10223	10364-105F4	46.90	41.57	6.40	0.53	0.00	0.00
granulocyte macrophage progenitor, donor1	12131-128D7	112.57	29.37	34.26	14.68	0.00	2.45
granulocyte macrophage progenitor, donor2	12135-128E2	54.64	43.71	65.57	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	62.72	26.13	94.08	20.91	10.45	0.00
granulosa cell tumor cell line:KGN	10624-108H3	68.48	26.56	11.20	1.92	0.64	0.00
hIPS +CCl2, biol_rep1	14383-156B9	25.71	14.23	0.00	0.00	0.00	0.00
hIPS +CCl2, biol_rep2	14384-156C1	18.75	14.63	0.00	0.00	0.00	0.00
hIPS +CCl2, biol_rep3	14385-156C2	32.85	17.39	0.64	0.00	0.00	0.00
hIPS, biol_rep1	14380-156B6	31.62	11.50	0.00	0.00	0.00	0.00
hIPS, biol_rep2	14381-156B7	33.61	12.35	0.00	0.00	0.00	0.00
hIPS, biol_rep3	14382-156B8	46.35	59.59	5.52	0.00	0.00	0.00
hairy cell leukemia cell line:Mo	10712-109I1	59.77	23.85	29.02	7.76	4.60	0.29
heart - mitral valve, adult	10205-103F7	57.70	19.73	11.96	2.69	1.49	0.60
heart - pulmonic valve, adult	10206-103F8	57.26	16.47	8.11	1.31	1.31	0.26
heart - tricuspid valve, adult	10207-103F9	63.28	17.49	7.49	1.67	0.83	0.00
heart, adult, diseased post-infarction, donor1	10050-101G5	77.13	12.86	3.47	2.45	0.41	0.00
heart, adult, diseased, donor1	10051-101G6	112.85	14.48	13.20	3.83	2.13	0.00
heart, adult, pool1	10016-101C7	99.58	17.94	16.79	5.75	1.15	0.00
heart, fetal, pool1	10046-101G1	56.06	18.79	9.96	1.75	0.72	0.21
hepatic mesenchymal tumor cell line:LI90	10778-110G4	59.55	13.58	19.44	4.94	2.47	0.31
hepatoblastoma cell line:HuH-6	10633-108I3	9.51	21.41	0.00	0.00	0.00	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	33.15	35.47	0.00	0.00	0.00	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	35.44	35.08	0.12	0.00	0.00	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	33.75	33.65	0.00	0.00	0.10	0.00
hepatoma cell line:Li-7	10484-107A7	52.49	39.70	0.11	0.00	0.00	0.00
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	22.41	57.39	0.00	0.00	0.00	0.00
hippocampus - adult, donor10196	10169-103B7	35.01	37.85	3.79	0.00	0.00	0.00
hippocampus, adult, donor10252	10153-102I9	50.41	47.96	2.25	0.82	0.20	0.00
hippocampus, adult, donor10258	10374-105G5	31.37	45.31	1.99	0.50	0.00	0.00
hippocampus, newborn, donor10223	10363-105F3	24.67	26.44	1.06	0.00	0.00	0.35
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	18.31	33.57	0.00	0.00	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	20.62	21.99	0.39	0.00	0.20	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	21.58	34.02	0.25	0.00	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	34.96	17.48	0.00	0.00	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	35.63	17.04	0.52	0.00	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	42.52	17.08	0.00	0.00	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	46.13	17.23	0.58	0.00	0.29	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	41.36	20.25	0.43	0.00	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	54.22	16.68	0.00	0.00	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	56.12	17.05	0.47	0.00	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	59.79	20.41	0.16	0.00	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	54.54	24.91	0.00	0.00	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	19.40	20.66	0.00	0.00	0.16	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	17.20	17.20	0.00	0.00	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	13.09	38.40	0.00	0.00	0.87	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	44.48	13.17	0.00	0.00	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	43.61	10.03	0.44	0.00	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	33.48	13.49	0.00	0.00	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	24.30	12.43	0.00	0.00	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	35.92	13.64	0.91	0.00	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	30.38	14.10	0.00	0.00	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	48.83	16.17	0.00	0.00	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	45.87	16.84	0.00	0.00	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	41.25	17.34	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	26.79	32.15	0.37	0.00	0.18	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	28.24	30.53	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	26.95	40.01	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	43.66	15.14	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	36.43	16.47	0.32	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	40.85	19.97	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	42.40	15.51	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	47.82	14.61	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	34.89	16.93	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	50.62	26.08	0.26	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	61.34	16.66	3.03	0.00	0.76	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	54.78	31.25	0.00	0.00	0.34	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	25.60	28.26	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	27.63	39.66	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	17.07	35.61	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	45.84	12.22	0.61	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	9.76	9.76	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	34.09	24.49	0.33	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	62.39	17.51	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	45.24	16.65	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	45.20	21.71	1.07	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	46.54	29.83	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	47.67	22.07	0.41	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	47.41	21.28	0.00	0.00	0.00	0.00
immature langerhans cells, donor1	11904-125F5	61.75	7.02	30.03	0.97	2.18	0.24
immature langerhans cells, donor2	11905-125F6	107.73	7.13	50.70	5.54	0.79	0.00
insula, adult, pool1	10039-101F3	31.32	46.84	4.83	1.70	0.19	0.00
keratoacanthoma cell line:HKA-1	10791-110H8	53.97	35.44	0.33	0.00	0.00	0.00
kidney, adult, pool1	10017-101C8	86.01	25.63	3.60	0.70	0.50	0.00
kidney, fetal, pool1	10045-101F9	62.81	21.57	2.05	1.13	0.57	0.14
large cell lung carcinoma cell line:IA-LM	10509-107D5	32.81	48.43	0.14	0.00	0.00	0.00
large cell lung carcinoma cell line:NCI-H460	10839-111E2	36.36	14.24	0.00	0.00	0.00	0.00
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	32.85	14.50	0.00	0.00	0.00	0.00
left atrium, adult, donor1	10079-102A7	59.93	17.44	22.88	3.27	3.27	1.09
left ventricle, adult, donor1	10078-102A6	71.80	15.17	13.15	1.52	2.02	0.00
leiomyoblastoma cell line:G-402	10721-110A1	47.33	17.24	0.00	0.00	0.00	0.00
leiomyoma cell line:10964C	10569-108B2	76.52	43.11	85.50	7.18	5.03	0.72
leiomyoma cell line:15242A	10570-108B3	75.00	33.70	34.24	4.35	1.09	1.09
leiomyoma cell line:15425	10571-108B4	91.06	35.94	47.11	10.44	2.91	0.73
leiomyosarcoma cell line:Hs 5.T	10722-110A2	88.89	25.40	76.19	6.35	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	37.64	12.55	0.00	0.00	0.00	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	44.63	20.42	48.05	6.02	2.48	0.35
liposarcoma cell line:KMLS-1	10782-110G8	48.74	28.90	4.37	2.03	0.78	0.47
liposarcoma cell line:SW 872	10726-110A6	74.57	35.33	0.00	0.00	0.00	0.00
liver, adult, pool1	10018-101C9	79.57	42.30	1.94	1.13	0.00	0.00
liver, fetal, pool1	10086-102B5	48.92	22.58	1.88	1.88	0.94	0.00
locus coeruleus - adult, donor10196	10182-103D2	43.75	53.52	9.19	1.02	0.29	0.29
locus coeruleus, adult, donor10252	10165-103B3	55.92	45.77	7.01	1.66	0.37	0.00
locus coeruleus, adult, donor10258	10375-105G6	74.20	69.12	19.75	2.82	1.13	0.28
locus coeruleus, newborn, donor10223	10362-105F2	25.66	37.01	2.10	0.42	0.00	0.00
lung adenocarcinoma cell line:A549	10499-107C4	32.52	57.57	0.00	0.00	0.00	0.00
lung adenocarcinoma cell line:PC-14	10408-106B3	22.06	8.27	0.00	0.00	0.00	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	25.70	23.60	0.00	0.13	0.00	0.00
lung, adult, pool1	10019-101D1	75.96	23.27	23.51	3.19	1.65	0.24
lung, fetal, donor1	10068-101I5	62.50	27.97	11.42	0.29	0.29	0.00
lung, right lower lobe, adult, donor1	10075-102A3	82.48	24.74	25.20	4.58	3.21	0.46
lymph node, adult, donor1	10077-102A5	50.65	17.99	22.72	4.26	3.31	1.42
lymphangiectasia cell line:DS-1	10727-110A7	49.10	26.30	0.00	0.22	0.22	0.00
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	22.79	22.49	0.00	0.00	0.00	0.00
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	28.88	16.99	0.00	0.00	0.00	0.00
mature adipocyte, donor1	12231-129F8	82.14	36.41	7.99	2.66	3.11	0.00
mature adipocyte, donor2	12232-129F9	54.99	22.21	6.02	1.04	0.21	0.00
mature adipocyte, donor3	12233-129G1	64.01	32.24	13.75	1.19	1.42	0.00
mature adipocyte, donor4	12234-129G2	50.54	28.69	4.21	0.79	1.05	0.00
maxillary sinus tumor cell line:HSQ-89	10414-106B9	30.50	26.92	0.00	0.00	0.00	0.00
medial frontal gyrus - adult, donor10196	10170-103B8	22.56	45.12	2.26	1.13	0.00	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	40.46	44.51	1.29	0.74	0.18	0.00
medial frontal gyrus, adult, donor10258	10368-105F8	29.54	46.70	0.64	0.00	0.00	0.32
medial frontal gyrus, newborn, donor10223	10352-105E1	5.54	28.15	0.00	0.00	0.00	0.00
medial temporal gyrus - adult, donor10196	10183-103D3	28.69	52.65	2.70	0.17	0.17	0.00
medial temporal gyrus, adult, donor10252	10156-103A3	46.48	46.05	3.61	1.06	0.21	0.42
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	26.97	57.79	0.00	0.00	1.93	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	0.00	71.77	0.00	0.00	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	20.82	26.20	1.44	0.36	0.36	0.00
medulla oblongata - adult, donor10196	10174-103C3	55.16	38.94	8.44	0.65	0.00	0.00
medulla oblongata, adult, donor10252	10155-103A2	50.62	40.56	3.41	1.86	0.31	0.15
medulla oblongata, adult, pool1	10038-101F2	47.26	40.00	16.08	3.35	1.06	0.41
medulla oblongata, newborn, donor10223	10361-105F1	44.44	37.15	1.04	2.43	0.35	0.00
medulloblastoma cell line:D283 Med	10838-111E1	23.47	33.21	0.00	0.00	0.00	0.00
medulloblastoma cell line:ONS-76	10759-110E3	59.67	59.91	0.00	0.00	0.00	0.00
melanoma cell line:COLO 679	10514-107E1	41.40	46.29	0.29	0.00	0.00	0.00
melanoma cell line:G-361	10465-106H6	32.30	55.92	0.27	0.00	0.00	0.27
meningioma cell line:HKBMM	10691-109F7	72.36	45.77	0.18	0.00	0.00	0.00
merkel cell carcinoma cell line:MKL-1	10843-111E6	23.79	5.29	0.88	0.00	0.00	0.00
merkel cell carcinoma cell line:MS-1	10844-111E7	51.84	25.14	0.00	0.00	0.00	0.00
mesenchymal precursor cell - adipose, donor1	11747-123G1	103.87	31.76	46.80	9.97	3.22	1.07
mesenchymal precursor cell - adipose, donor2	11748-123G2	68.53	26.18	39.99	10.18	3.45	1.09
mesenchymal precursor cell - adipose, donor3	11749-123G3	77.85	31.06	89.45	9.11	1.66	2.07
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	62.79	23.04	36.10	9.13	3.23	0.84
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	79.92	22.72	36.20	12.52	2.89	0.96
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	93.01	57.61	81.21	11.11	3.47	1.39
mesenchymal precursor cell - cardiac, donor1	11752-123G6	67.45	30.55	104.01	10.81	3.43	2.06
mesenchymal precursor cell - cardiac, donor2	11753-123G7	72.00	28.41	98.22	12.31	5.06	2.76
mesenchymal precursor cell - cardiac, donor3	11754-123G8	69.63	23.74	34.35	7.30	2.12	1.19
mesenchymal precursor cell - cardiac, donor4	11755-123G9	62.12	16.61	18.77	3.92	1.22	0.41
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	60.32	13.94	10.81	5.55	1.14	0.28
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	53.03	20.75	14.16	4.61	0.33	0.66
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	63.24	14.67	13.84	6.23	1.38	0.28
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	99.49	30.02	68.77	12.92	5.59	2.09
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	70.64	16.33	42.47	8.57	3.47	1.84
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	87.71	19.05	30.55	8.63	1.80	2.16
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	73.04	19.03	38.38	12.21	3.83	2.07
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	59.73	17.33	78.43	8.66	4.56	1.14
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	61.26	20.56	28.53	7.55	1.26	1.26
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	64.56	20.02	11.06	4.18	0.45	0.15
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	67.22	17.07	29.15	10.85	2.10	1.49
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	92.41	29.45	26.88	8.84	1.84	1.10
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	77.83	12.02	30.33	7.44	3.43	0.57
mesenchymal stem cell line:Hu5/E18	10568-108B1	100.20	29.47	8.84	0.84	0.84	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	127.87	46.12	79.92	12.33	3.65	1.83
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	110.75	39.65	83.39	7.42	3.84	1.79
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	116.74	38.48	85.86	9.16	4.71	2.09
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	102.59	40.67	79.49	9.24	2.46	0.92
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	97.44	40.72	88.73	8.00	4.24	1.18
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	104.92	45.35	80.89	9.14	2.37	1.69
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	110.82	45.98	93.92	9.82	3.14	0.39
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	99.63	40.78	92.21	8.34	4.63	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	0.00	0.00	96.61	0.00	0.00	48.30
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	136.42	46.72	98.35	11.83	6.35	2.60
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	98.61	44.40	86.12	8.92	3.79	0.67
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	104.07	46.15	80.28	10.34	4.81	1.92
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	77.00	23.47	38.87	5.13	1.47	1.47
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	99.35	48.33	87.94	9.06	2.35	1.68
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	90.06	50.76	97.43	9.83	2.87	0.41
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	106.10	48.97	81.62	6.87	2.58	0.86
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	155.86	57.42	131.25	13.67	0.00	5.47
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	139.45	36.15	82.64	0.00	10.33	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	114.00	48.07	94.19	9.42	4.22	0.65
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	157.14	52.38	88.75	10.18	10.18	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	158.86	63.97	134.34	14.39	4.26	3.20
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	107.13	53.97	88.32	13.90	4.91	1.64
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	124.00	54.03	90.57	15.55	2.72	2.72
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	161.60	50.37	90.25	4.20	2.10	2.10
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	124.18	50.67	105.31	9.93	5.96	0.99
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	100.11	52.44	123.95	14.30	4.77	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	131.64	47.44	93.69	12.45	5.93	1.19
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	123.06	63.36	75.54	6.09	4.87	2.44
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	162.31	162.31	54.10	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	155.18	48.77	95.01	10.77	5.70	1.90
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	114.51	40.35	64.50	7.93	2.76	0.69
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	105.31	45.13	68.77	15.04	2.15	2.15
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	111.77	27.94	31.93	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	92.98	44.77	24.11	10.33	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	76.20	37.49	30.56	9.78	1.22	0.81
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	72.29	32.57	43.69	9.53	0.79	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	71.92	39.50	24.17	8.84	2.95	1.18
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	62.03	33.04	28.37	7.17	1.25	0.94
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	74.85	37.43	30.74	10.69	1.34	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	54.40	30.75	14.19	10.64	1.18	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	79.61	43.66	20.54	5.14	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	70.22	33.73	23.41	8.26	0.69	2.75
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	69.77	22.76	7.42	2.97	0.49	0.49
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	66.17	34.77	13.46	1.12	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	55.97	31.80	9.54	0.00	0.64	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	76.57	31.03	12.49	2.01	0.40	0.40
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	71.96	34.89	13.08	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	93.76	22.81	8.87	0.00	1.27	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	69.19	38.23	20.63	4.86	0.61	0.61
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	81.34	36.15	27.11	4.52	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	79.90	47.77	15.65	4.12	3.29	0.82
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	73.02	31.95	44.84	4.56	2.18	0.20
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	71.71	24.66	49.00	8.11	4.22	0.97
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	95.75	38.71	49.91	3.06	1.02	1.02
mesodermal tumor cell line:HIRS-BM	10696-109G3	27.85	41.78	0.00	0.00	0.00	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	48.90	40.87	0.00	0.00	0.00	0.00
mesothelioma cell line:ACC-MESO-4	10494-107B8	28.73	16.91	30.81	8.11	0.70	1.16
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	81.20	47.01	12.82	0.00	4.27	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	83.64	83.02	34.83	2.98	2.67	0.10
mesothelioma cell line:Mero-25	10850-111F4	68.54	48.80	39.94	4.54	0.91	0.45
mesothelioma cell line:Mero-41	10851-111F5	82.14	41.32	10.02	2.69	0.49	0.24
mesothelioma cell line:Mero-48a	10852-111F6	64.21	38.53	0.66	0.22	0.00	0.00
mesothelioma cell line:Mero-82	10853-111F7	89.09	48.09	1.31	0.00	0.00	0.00
mesothelioma cell line:Mero-83	10854-111F8	55.15	21.96	0.51	0.34	0.00	0.00
mesothelioma cell line:Mero-84	10855-111F9	27.30	6.07	16.94	5.06	0.25	0.00
mesothelioma cell line:Mero-95	10856-111G1	69.15	32.71	60.46	7.04	2.28	1.24
mesothelioma cell line:NCI-H2052	10847-111F1	83.16	36.44	3.98	1.33	0.17	0.17
mesothelioma cell line:NCI-H226	10846-111E9	58.10	32.76	32.40	10.68	1.99	1.27
mesothelioma cell line:NCI-H2452	10848-111F2	92.41	37.07	65.08	10.08	3.59	0.34
mesothelioma cell line:NCI-H28	10845-111E8	45.80	28.25	0.00	0.00	0.00	0.00
mesothelioma cell line:No36	10857-111G2	70.79	58.06	0.00	0.33	0.00	0.00
mesothelioma cell line:ONE58	10858-111G3	92.94	39.83	12.46	1.35	1.08	0.00
migratory langerhans cells, donor1	11901-125F2	73.12	6.33	53.55	7.29	7.48	0.00
migratory langerhans cells, donor2	11902-125F3	82.79	7.94	49.21	7.94	5.01	0.61
migratory langerhans cells, donor3	11903-125F4	70.54	10.41	30.33	7.00	1.97	0.36
mixed mullerian tumor cell line:HTMMT	10689-109F5	90.76	117.53	1.63	0.00	0.00	0.00
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	73.33	71.42	0.21	0.00	0.00	0.00
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	61.51	53.44	0.00	0.00	0.00	0.00
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	47.38	31.78	0.00	3.62	0.00	0.00
myelodysplastic syndrome cell line:SKM-1	10772-110F7	60.06	98.12	3.88	2.59	0.18	0.00
myeloma cell line:PCM6	10474-106I6	69.78	23.32	225.93	13.05	7.12	0.99
myxofibrosarcoma cell line:MFH-ino	10600-108E6	61.38	32.47	0.00	0.00	0.00	0.00
myxofibrosarcoma cell line:NMFH-1	10684-109E9	54.33	24.52	4.90	1.37	0.20	0.00
nasal epithelial cells, donor1, tech_rep1	12226-129F3	128.92	49.14	17.16	0.45	0.45	0.00
nasal epithelial cells, donor1, tech_rep2	12226-129F3	112.74	58.76	16.77	0.37	1.25	0.00
nasal epithelial cells, donor2	12227-129F4	96.05	27.05	23.18	1.66	1.10	0.00
neuroblastoma cell line:CHP-134	10508-107D4	17.48	26.46	0.00	0.00	0.00	0.00
neuroblastoma cell line:NB-1	10539-107G8	28.06	17.59	0.19	0.00	0.00	0.00
neuroblastoma cell line:NBsusSR	10607-108F4	27.20	47.45	0.21	0.00	0.00	0.00
neuroblastoma cell line:NH-12	10555-107I6	35.22	17.89	0.00	0.00	0.00	0.00
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	23.25	47.68	0.24	0.00	0.00	0.00
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	76.66	33.74	14.25	2.38	1.74	0.48
neuroectodermal tumor cell line:TASK1	10774-110F9	37.64	57.16	0.00	0.00	0.20	0.00
neuroepithelioma cell line:SK-N-MC	10728-110A8	55.31	43.23	0.00	0.00	0.00	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	97.68	24.49	34.60	5.06	1.33	0.80
neutrophil PMN, donor1	12133-128D9	59.50	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	53.12	39.84	0.00	13.28	0.00	0.00
neutrophil PMN, donor3	12141-128E8	28.41	0.00	9.47	9.47	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	32.98	34.33	0.00	0.00	0.00	0.00
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	23.21	30.42	0.00	0.00	0.00	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	101.63	32.70	5.45	2.24	0.96	0.00
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	79.88	43.88	3.15	0.53	0.53	0.26
nucleus accumbens, adult, pool1	10037-101F1	39.09	49.87	5.34	1.22	0.75	0.37
occipital cortex - adult, donor10196	10172-103C1	24.72	45.33	4.12	2.06	0.00	0.00
occipital cortex, adult, donor10252	10163-103B1	52.33	51.53	4.83	1.07	0.00	0.27
occipital cortex, newborn, donor10223	10355-105E4	28.39	36.03	1.82	1.46	0.00	0.00
occipital lobe, adult, donor1	10076-102A4	45.66	56.94	9.18	2.36	0.00	0.00
occipital lobe, fetal, donor1	10073-102A1	39.05	37.76	0.43	0.00	0.00	0.00
occipital pole, adult, pool1	10036-101E9	37.29	41.00	9.78	1.81	0.32	0.16
olfactory region, adult	10195-103E6	38.21	49.48	3.25	0.76	0.00	0.19
optic nerve, donor1	10277-104E7	84.04	72.04	42.02	10.01	0.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	33.03	35.20	0.11	0.00	0.11	0.00
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	49.73	51.25	0.14	0.00	0.00	0.00
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	79.58	27.60	0.00	0.00	0.00	0.00
oral squamous cell carcinoma cell line:SAS	10544-107H4	30.61	18.02	0.12	0.00	0.00	0.00
osteoclastoma cell line:Hs 706.T	10704-109H2	86.13	18.23	13.52	3.23	1.76	0.29
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	30.83	10.28	0.00	0.00	0.00	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	44.53	16.54	20.57	1.06	1.70	0.42
ovary, adult, pool1	10020-101D2	71.89	37.74	9.78	1.40	1.22	0.09
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	59.03	37.21	0.73	0.18	0.00	0.00
pancreas, adult, donor1	10049-101G4	56.44	34.80	0.94	0.94	0.94	0.00
pancreatic carcinoma cell line:NOR-P1	10698-109G5	23.20	11.74	0.00	0.00	0.00	0.00
papillary adenocarcinoma cell line:8505C	10437-106E5	86.71	71.55	0.85	0.17	0.00	0.00
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	26.82	21.19	0.00	0.00	0.00	0.00
paracentral gyrus, adult, pool1	10035-101E8	34.32	38.71	9.79	2.01	0.55	0.09
parietal cortex, adult, donor10258	10373-105G4	27.89	49.91	0.73	1.47	0.00	0.00
parietal lobe - adult, donor10196	10171-103B9	29.15	59.25	1.88	0.00	0.94	0.94
parietal lobe, adult, donor10252	10157-103A4	35.63	43.04	1.14	0.86	0.00	0.00
parietal lobe, adult, pool1	10034-101E7	36.04	45.12	9.34	2.11	0.44	0.09
parietal lobe, fetal, donor1	10072-101I9	26.19	42.67	0.00	0.00	0.00	0.00
parietal lobe, newborn, donor10223	10356-105E5	16.82	32.53	1.50	0.37	0.00	0.00
parotid gland, adult	10199-103F1	77.70	30.22	3.70	0.00	0.00	0.00
penis, adult	10200-103F2	69.82	19.34	10.74	0.54	2.15	0.00
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	32.35	40.53	3.16	0.00	0.00	0.00
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	59.30	23.46	0.00	0.00	0.00	0.00
pineal gland - adult, donor10196	10179-103C8	45.15	29.67	0.65	0.00	0.65	0.00
pineal gland, adult, donor10252	10160-103A7	32.57	24.87	1.18	0.00	0.00	0.00
pineal gland, adult, donor10258	10377-105G8	31.35	38.25	0.63	0.63	0.00	0.00
pituitary gland - adult, donor10196	10180-103C9	68.80	45.53	1.01	1.01	0.00	0.00
pituitary gland, adult, donor10252	10162-103A9	49.51	33.88	1.04	0.00	0.00	0.00
pituitary gland, adult, donor10258	10378-105G9	44.26	72.36	0.85	0.00	0.00	0.00
placenta, adult, pool1	10021-101D3	74.61	25.05	9.14	1.72	1.72	0.11
plasma cell leukemia cell line:ARH-77	10840-111E3	15.36	28.87	0.13	1.19	0.00	0.00
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	30.51	6.69	1.09	0.00	0.16	0.00
pons, adult, pool1	10033-101E6	37.53	33.57	13.94	1.64	0.34	0.34
postcentral gyrus, adult, pool1	10032-101E5	40.62	48.38	10.64	2.09	0.35	0.26
promyelocytes/myelocytes PMC, donor1	12132-128D8	60.65	16.73	18.82	4.18	2.09	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	71.60	38.56	66.10	16.52	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	70.41	0.00	117.36	0.00	0.00	11.74
prostate cancer cell line:DU145	10490-107B4	40.93	35.83	0.00	0.00	0.00	0.00
prostate cancer cell line:PC-3	10439-106E7	79.13	38.12	0.18	0.00	0.36	0.00
prostate, adult, pool1	10022-101D4	69.20	34.92	5.08	0.54	0.54	0.00
putamen, adult, donor10196	10176-103C5	36.83	63.74	1.18	0.47	0.00	0.00
putamen, adult, donor10252	10152-102I8	49.02	60.78	3.92	1.96	0.00	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	26.23	43.71	1.09	0.00	1.09	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	38.17	50.26	0.97	0.24	0.00	0.24
putamen, newborn, donor10223	10365-105F5	27.74	43.48	0.00	1.50	0.00	0.00
rectal cancer cell line:TT1TKB	10469-106I1	24.73	22.98	0.00	0.00	0.00	0.00
rectum, fetal, donor1	10067-101I4	76.50	26.43	2.78	1.39	1.39	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	36.25	54.06	0.00	0.00	0.00	0.00
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	42.25	41.01	0.00	0.00	0.00	0.00
retina, adult, pool1	10030-101E3	71.57	34.29	6.96	1.19	1.19	0.10
retinoblastoma cell line:Y79	10475-106I7	25.72	28.32	0.00	0.00	0.00	0.00
rhabdomyosarcoma cell line:KYM-1	10787-110H4	29.88	29.14	0.12	0.00	0.00	0.00
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	32.06	34.59	0.00	0.00	0.00	0.00
sacrococcigeal teratoma cell line:HTST	10695-109G2	51.53	25.01	4.55	1.52	0.76	1.52
salivary acinar cells, donor1	11771-123I7	40.79	16.02	19.42	0.32	1.13	0.00
salivary acinar cells, donor2	11772-123I8	51.50	19.14	64.58	2.20	1.10	0.14
salivary acinar cells, donor3	11773-123I9	54.95	25.82	20.52	0.66	0.00	0.00
salivary gland, adult, pool1	10093-102C3	62.91	25.74	1.14	1.14	0.00	0.57
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	51.94	86.17	19.48	4.05	1.35	0.51
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	57.95	82.17	20.45	5.05	2.47	0.59
seminal vesicle, adult	10201-103F3	64.02	30.16	2.12	0.00	0.00	0.00
serous adenocarcinoma cell line:JHOS-2	10639-108I9	57.57	18.95	0.97	0.00	0.00	0.00
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	101.16	22.14	0.25	0.00	0.00	0.00
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	122.43	44.16	0.00	0.00	0.00	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	71.19	55.61	0.13	0.00	0.00	0.00
signet ring carcinoma cell line:Kato III	10436-106E4	19.34	18.46	0.55	0.00	0.00	0.00
signet ring carcinoma cell line:NUGC-4	10483-107A6	28.26	34.06	0.00	0.00	0.00	0.00
skeletal muscle - soleus muscle, donor1	10282-104F3	63.13	7.80	0.00	0.71	0.00	0.00
skeletal muscle, adult, pool1	10023-101D5	103.63	29.26	6.00	0.36	1.08	0.00
skeletal muscle, fetal, donor1	10066-101I3	65.33	29.15	7.04	1.01	0.00	0.00
skin, adult, donor1	10074-102A2	88.21	13.57	40.71	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	59.97	18.94	12.62	1.26	1.89	0.00
small cell cervical cancer cell line:HCSC-1	10800-110I8	24.68	29.35	0.00	0.00	0.00	0.00
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	26.79	18.28	0.00	0.00	0.00	0.00
small cell lung carcinoma cell line:DMS 144	10841-111E4	23.71	48.77	0.00	0.00	0.00	0.00
small cell lung carcinoma cell line:LK-2	10541-107H1	10.88	15.82	0.00	0.00	0.00	0.00
small cell lung carcinoma cell line:NCI-H82	10842-111E5	19.30	23.81	0.16	0.00	0.00	0.00
small cell lung carcinoma cell line:WA-hT	10562-108A4	35.08	36.39	0.00	0.00	0.00	0.00
small intestine, adult, pool1	10024-101D6	61.75	26.52	3.46	0.48	0.12	0.12
small intestine, fetal, donor1	10064-101I1	46.44	18.92	2.21	0.49	0.00	0.00
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	15.39	28.72	0.00	0.00	0.00	0.00
smooth muscle, adult, pool1	10048-101G3	78.31	27.14	5.69	2.33	0.52	0.00
somatostatinoma cell line:QGP-1	10781-110G7	30.29	20.91	0.00	0.00	0.00	0.00
spinal cord - adult, donor10196	10181-103D1	60.56	59.65	12.85	3.21	1.15	0.00
spinal cord, adult, donor10252	10159-103A6	41.00	47.31	2.76	2.37	0.39	0.00
spinal cord, adult, donor10258	10369-105F9	47.73	76.10	8.99	2.08	2.77	0.00
spinal cord, fetal, donor1	10056-101H2	65.25	27.44	6.10	2.44	0.61	0.00
spinal cord, newborn, donor10223	10359-105E8	33.98	33.52	4.59	1.38	0.46	0.00
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	74.53	20.61	26.14	8.96	2.39	0.45
spleen, adult, pool1	10025-101D7	51.10	18.06	11.23	4.19	0.33	0.33
spleen, fetal, pool1	10044-101F8	57.84	18.43	10.09	3.18	0.95	0.08
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	20.39	24.95	4.97	1.45	0.62	0.00
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	28.48	19.56	0.00	0.00	0.00	0.00
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	50.32	17.47	2.45	0.00	0.35	0.00
squamous cell carcinoma cell line:T3M-5	10616-108G4	55.12	77.01	0.00	0.00	0.00	0.00
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	44.91	54.82	0.00	0.00	0.00	0.00
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	45.33	24.15	0.42	0.00	0.00	0.00
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	66.42	27.08	0.85	0.00	0.42	0.00
stomach, fetal, donor1	10062-101H8	52.33	12.82	5.34	1.07	1.07	0.00
submaxillary gland, adult	10202-103F4	56.97	23.36	3.99	0.57	0.57	0.00
substantia nigra - adult, donor10196	10178-103C7	162.82	162.82	108.55	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	74.15	67.30	16.20	3.32	1.25	0.21
substantia nigra, adult, donor10258	10371-105G2	51.21	45.00	9.83	1.03	0.00	0.00
substantia nigra, newborn, donor10223	10358-105E7	34.62	50.17	2.12	0.00	0.00	0.00
synovial sarcoma cell line:HS-SY-II	10441-106E9	30.49	37.83	0.23	0.00	0.00	0.00
temporal lobe, adult, pool1	10031-101E4	51.46	51.54	10.68	2.46	0.42	0.34
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	34.19	30.63	0.00	0.00	0.00	0.00
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	31.21	31.21	0.44	0.00	0.44	0.00
tenocyte, donor1	11763-123H8	113.81	40.84	60.74	9.43	5.93	1.05
tenocyte, donor2	11765-123I1	89.27	41.58	71.34	10.30	5.72	0.76
tenocyte, donor3	11768-123I4	121.21	48.19	116.76	11.49	5.19	1.48
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	29.23	29.23	0.17	0.00	0.00	0.00
teratocarcinoma cell line:NCR-G1	10798-110I6	21.89	16.34	0.15	0.00	0.00	0.00
teratocarcinoma cell line:PA-1	10807-111A6	23.09	24.18	0.00	0.00	0.00	0.00
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	14.60	11.30	0.51	0.13	0.13	0.00
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	27.98	42.73	0.00	0.00	0.00	0.00
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	12.00	26.50	0.00	0.00	0.00	0.00
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	32.57	22.15	0.33	0.00	0.00	0.00
testis, adult, pool1	10026-101D8	128.52	45.42	12.03	1.72	1.40	0.43
testis, adult, pool2	10096-102C6	136.23	67.21	6.32	0.45	0.00	0.00
thalamus - adult, donor10196	10168-103B6	66.24	70.66	9.94	2.21	0.00	1.10
thalamus, adult, donor10252	10154-103A1	66.26	62.67	7.03	1.72	0.63	0.16
thalamus, adult, donor10258, tech_rep1	10370-105G1	70.82	137.03	4.62	4.62	0.00	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	50.23	45.29	10.38	1.98	0.66	0.49
thalamus, newborn, donor10223	10366-105F6	16.11	25.89	0.58	0.58	0.00	0.00
throat, adult	10209-103G2	62.17	22.22	13.73	0.75	0.50	0.00
throat, fetal, donor1	10061-101H7	51.50	22.55	5.79	1.22	0.30	0.00
thymic carcinoma cell line:Ty-82	10803-111A2	34.98	53.06	3.58	0.60	0.00	0.20
thymus, adult, pool1	10027-101D9	46.33	12.03	4.87	0.99	0.60	0.30
thymus, fetal, pool1	10043-101F7	41.35	12.68	7.38	0.94	0.10	0.31
thyroid carcinoma cell line:KHM-5M	10776-110G2	69.94	56.91	0.00	0.00	0.00	0.00
thyroid carcinoma cell line:TCO-1	10783-110G9	79.34	39.81	47.22	4.33	3.49	0.14
thyroid, adult, pool1	10028-101E1	85.66	70.82	6.35	0.65	0.65	0.00
thyroid, fetal, donor1	10060-101H6	55.37	22.94	7.12	1.58	0.53	0.00
tongue epidermis (fungiform papillae), donor1	10288-104F9	73.91	15.40	12.32	0.00	0.00	0.00
tongue, adult	10203-103F5	74.66	21.40	26.75	1.16	0.70	0.23
tongue, fetal, donor1	10059-101H5	79.61	21.68	8.28	0.39	1.18	0.39
tonsil, adult, pool1	10047-101G2	68.32	23.14	13.22	2.30	0.80	0.20
trachea, adult, pool1	10029-101E2	69.12	18.90	7.44	1.96	0.74	0.16
trachea, fetal, donor1	10058-101H4	64.63	22.31	10.00	1.54	0.38	0.38
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	94.24	25.15	44.28	6.73	2.48	0.35
transitional-cell carcinoma cell line:5637	10418-106C4	26.44	25.53	0.00	0.00	0.00	0.00
transitional-cell carcinoma cell line:JMSU1	10492-107B6	32.90	43.25	0.16	0.00	0.00	0.00
tridermal teratoma cell line:HGRT	10694-109G1	36.15	30.44	1.90	0.00	0.00	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	49.52	18.96	0.00	0.00	0.00	0.00
umbilical cord, fetal, donor1	10057-101H3	64.68	10.43	8.35	0.00	0.00	2.09
uterus, adult, pool1	10100-102D1	75.08	23.38	6.31	0.85	0.34	0.17
uterus, fetal, donor1	10055-101H1	69.62	19.97	15.87	2.56	2.05	1.54
vagina, adult	10204-103F6	57.51	27.14	10.99	1.29	0.00	0.00
vein, adult	10191-103E2	60.94	26.08	13.81	2.41	1.53	0.00
xeroderma pigentosum b cell line:XPL 17	10563-108A5	29.37	21.10	3.47	3.74	0.53	0.27